2019 N-SSATS Tables

Table 2.1. Facility turnover: Number and column percent distribution, 2009–2019
	Number of facilities
Facility status	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019
Total	13,513	13,339	13,720	14,311	14,148	14,152	13,873	14,399	13,585	14,809	15,961
Responded to both current and prior year's surveys	12,065	11,882	11,943	12,230	12,711	12,643	12,564	12,500	12,400	12,334	13,107
New in survey year or non-respondents in previous year	1,448	1,457	1,777	2,081	1,437	1,509	1,309	1,899	1,185	2,475	2,854
Closed/non-respondents since previous survey year	1,623	1,631	1,396	1,490	1,600	1,505	1,588	1,373	1,999	1,251	1,702
	Column percent distribution of facilities
Total	100.0	100.0	100.0	100.0	100.0	100.0	100.0	100.0	100.0	100.0	100.0
Responded to both current and prior year's surveys	89.3	89.1	87.0	85.5	89.8	89.3	90.6	86.8	91.3	83.3	82.1
New in survey year or non-respondents in previous year	10.7	10.9	13.0	14.5	10.2	10.7	9.4	13.2	8.7	16.7	17.9
Closed/non-respondents since previous survey year	11.9	12.1	10.5	10.9	11.2	10.6	11.2	9.9	13.9	9.2	11.5
NOTES: Survey reference dates were: March 31 for 2009–2011 and 2014–2017; March 30 for 2012 and 2018; and March 29 for 2013 and 2019. See Appendix A for changes in the survey base, methods, and instruments that affect analysis of trends over time. Percentages may not sum to 100 percent because of rounding.
SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services (N-SSATS), 2009–2019.

Table 2.2. Facility operation: Number and column percent distribution, 2009–2019
	Number of facilities						Column percent distribution of facilities
Facility operation	2009	2011	2013	2015	2017	2019	2009	2011	2013	2015	2017	2019
Total	13,513	13,720	14,148	13,873	13,585	15,961	100.0	100.0	100.0	100.0	100.0	100.0
Facility operation
Private non-profit	7,826	7,869	7,820	7,577	7,163	8,043	57.9	57.4	55.3	54.6	52.7	50.4
Private for-profit	3,959	4,194	4,575	4,659	4,931	6,327	29.3	30.6	32.3	33.6	36.3	39.6
Local, county, or community govt.	795	742	739	702	640	694	5.9	5.4	5.2	5.1	4.7	4.3
State government	401	351	351	350	304	310	3.0	2.6	2.5	2.5	2.2	1.9
Federal government	341	348	370	321	289	333	2.5	2.5	2.6	2.3	2.1	2.1
Dept. of Veterans Affairs	210	225	228	203	183	222	1.6	1.6	1.6	1.5	1.3	1.4
Dept. of Defense	91	89	88	80	74	69	0.7	0.6	0.6	0.6	0.5	0.4
Indian Health Service	38	30	42	31	27	31	0.3	0.2	0.3	0.2	0.2	0.2
Other	2	4	12	7	5	11	*	*	0.1	0.1	*	0.1
Tribal government	191	216	293	264	258	254	1.4	1.6	2.1	1.9	1.9	1.6
* Less than 0.05 percent.
NOTES: Survey reference dates were March 31 for 2009, 2011, 2015, and 2017; and March 29 for 2013 and 2019. See Appendix A for changes in the survey base, methods, and instruments that affect analysis of trends over time. Percentages may not sum to 100 percent because of rounding.
SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services (N-SSATS), 2009–2019.

Table 2.3. All facilities and facilities with opioid treatment programs (OTPs), by type of care offered: Number and column percent, 2009–2019
Type of care offered and facilities with opioid treatment programs	Number of facilities¹						Column percent of facilities¹
	2009	2011	2013	2015	2017	2019	2009	2011	2013	2015	2017	2019
Total	13,513	13,720	14,148	13,873	13,585	15,961
Type of care offered
Outpatient	10,905	11,101	11,542	11,336	11,184	13,044	80.7	80.9	81.6	81.7	82.3	81.7
Regular	10,050	10,295	10,771	10,582	10,437	12,114	74.4	75.0	76.1	76.3	76.8	75.9
Intensive	5,991	6,089	6,363	6,261	6,241	7,325	44.3	44.4	45.0	45.1	45.9	45.9
Detoxification	1,296	1,294	1,362	1,350	1,366	1,752	9.6	9.4	9.6	9.7	10.1	11.0
Day treatment/partial hospitalization	1,726	1,702	1,742	1,747	1,805	2,255	12.8	12.4	12.3	12.6	13.3	14.1
Methadone/buprenorphine maintenance or naltrexone treatment	1,620	1,223	1,848	2,673	3,395	5,256	12.0	8.9	13.1	19.3	25.0	32.9
Residential (non-hospital)	3,520	3,524	3,450	3,383	3,125	3,794	26.0	25.7	24.4	24.4	23.0	23.8
Detoxification	879	890	861	887	908	1,410	6.5	6.5	6.1	6.4	6.7	8.8
Short-term treatment (30 days or fewer)	1,671	1,779	1,736	1,740	1,738	2,386	12.4	13.0	12.3	12.5	12.8	14.9
Long-term treatment (more than 30 days)	2,861	2,881	2,858	2,769	2,513	2,958	21.2	21.0	20.2	20.0	18.5	18.5
Hospital inpatient	797	740	753	724	715	898	5.9	5.4	5.3	5.2	5.3	5.6
Detoxification	713	658	660	639	655	806	5.3	4.8	4.7	4.6	4.8	5.0
Treatment	555	548	547	527	532	680	4.1	4.0	3.9	3.8	3.9	4.3
Facilities with opioid treatment programs²
Total	1,239	1,189	1,282	1,349	1,317	1,691
Outpatient	1,121	1,111	1,177	1,235	1,218	1,546	90.5	93.4	91.8	91.5	92.5	91.4
Regular	758	764	885	941	929	1,220	61.2	64.3	69.0	69.8	70.5	72.1
Intensive	310	315	346	351	334	496	25.0	26.5	27.0	26.0	25.4	29.3
Detoxification	602	584	619	591	620	704	48.6	49.1	48.3	43.8	47.1	41.6
Day treatment/partial hospitalization	100	72	80	76	67	96	8.1	6.1	6.2	5.6	5.1	5.7
Methadone/buprenorphine maintenance or naltrexone treatment	1,051	1,059	1,121	1,190	1,190	1,510	84.8	89.1	87.4	88.2	90.4	89.3
Residential (non-hospital)	126	90	98	112	106	144	10.2	7.6	7.6	8.3	8.0	8.5
Detoxification	69	48	47	54	62	91	5.6	4.0	3.7	4.0	4.7	5.4
Short-term treatment (30 days or fewer)	96	74	73	84	80	121	7.7	6.2	5.7	6.2	6.1	7.2
Long-term treatment (more than 30 days)	65	50	54	58	62	69	5.2	4.2	4.2	4.3	4.7	4.1
Hospital inpatient	144	100	108	106	95	144	11.6	8.4	8.4	7.9	7.2	8.5
Detoxification	135	97	98	96	92	132	10.9	8.2	7.6	7.1	7.0	7.8
Treatment	101	77	79	75	64	102	8.2	6.5	6.2	5.6	4.9	6.0
¹ Numbers of facilities sum to more than the total and percentages sum to more than 100, because a facility could provide more than one type of care.
² Only those facilities that have opioid treatment programs certified by the Substance Abuse and Mental Health Services Administration are included.
NOTES: Survey reference dates were March 31 for 2009, 2011, 2015, and 2017; and March 29 for 2013 and 2019. See Appendix A for changes in the survey base, methods, and instruments that affect analysis of trends over time. Methadone is available only at OTP facilities that are certified by SAMHSA’s Center for Substance Abuse Treatment. Buprenorphine may be prescribed by medical practitioners who have received DATA 2000-specific training and received a waiver to prescribe the medication for treatment of opioid use disorder. Naltrexone may be prescribed by any medical practitioner with prescribing privileges. This report does not include clients who were prescribed buprenorphine through an independent DATA 2000-waivered medical practitioner or naltrexone through an independent practitioner not affiliated with a substance abuse treatment facility.
SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services (N-SSATS), 2009–2019.

Table 2.4. Medication-assisted opioid therapy provided at facilities with OTPs and non-OTP facilities: Number and column percent, 2009–2019
Facilities with opioid treatment programs and other facilities	Number of facilities						Column percent of facilities
	2009	2011	2013	2015	2017	2019	2009	2011	2013	2015	2017	2019
Total	13,513	13,720	14,148	13,873	13,585	15,961
Any MAT type¹	2,926	3,609	4,175	4,602	5,143	7,770	21.7	26.3	29.5	33.2	37.9	48.7
Total OTPs	1,239	1,189	1,282	1,349	1,317	1,691	9.2	8.7	9.1	9.7	9.7	10.6
Total buprenorphine²	2,290	2,694	3,113	3,404	3,900	6,497	16.9	19.6	22.0	24.5	28.7	40.7
Total injectable naltrexone	n/a	1,093	1,718	2,274	3,197	5,594	n/a	8.0	12.1	16.4	23.5	35.0
Facilities with opioid treatment programs³	1,239	1,189	1,282	1,349	1,317	1,691
Any MAT type¹	1,239	1,184	1,262	1,335	1,317	1,691	100.0	99.6	98.4	99.0	100.0	100.0
Methadone only	636	575	565	522	418	349	51.3	48.4	44.1	38.7	31.7	20.6
Methadone and buprenorphine²	555	467	456	476	509	647	44.8	39.3	35.6	35.3	38.6	38.3
Methadone, buprenorphine², and injectable naltrexone	n/a	113	188	247	309	536	n/a	9.5	14.7	18.3	23.5	31.7
Methadone and injectable naltrexone	n/a	5	13	31	35	50	n/a	0.4	1.0	2.3	2.7	3.0
Buprenorphine²and injectable naltrexone	n/a	4	13	34	31	86	n/a	0.3	1.0	2.5	2.4	5.1
Buprenorphine² only	48	17	25	22	14	20	3.9	1.4	2.0	1.6	1.1	1.2
Injectable naltrexone only	n/a	8	22	17	1	3	n/a	0.7	1.7	1.3	0.1	0.2
Total buprenorphine	2,290	2,694	3,113	3,404	3,900	6,497
OTPs providing buprenorphine²	603	601	682	779	863	1,289	26.3	22.3	21.9	22.9	22.1	19.8
Non-OTP facilities providing buprenorphine²	1,687	2,093	2,431	2,625	3,037	5,208	73.7	77.7	78.1	77.1	77.9	80.2
Total injectable naltrexone	n/a	1,093	1,718	2,274	3,197	5,594
OTPs providing injectable naltrexone	n/a	125	216	315	376	675	n/a	11.4	12.6	13.9	11.8	12.1
Non-OTP facilities providing buprenorphine² and injectable naltrexone	n/a	636	1,020	1,317	2,032	4,048	n/a	58.2	59.4	57.9	63.6	72.4
Non-OTP facilities providing injectable naltrexone only	n/a	332	482	642	789	871	n/a	30.4	28.1	28.2	24.7	15.6
n/a Not applicable.
Injectable naltrexone = extended-release injectable naltrexone; MAT = medication assisted treatment.
¹Any MAT type for all facilities providing medication-assisted opioid therapy includes all facilities providing buprenorphine or injectable naltrexone and OTP facilities providing methadone, buprenorphine, or injectable naltrexone.
² Buprenorphine includes buprenorphine with and without naloxone, buprenorphine sub-dermal implant, and extended-release injectable buprenorphine.
³ The numbers in this category will not sum to the number of all facilities with OTPs because naltrexone only is not included due to the differences in the question asked over the time period.
NOTES: Survey reference dates were March 31 for 2009, 2011, 2015, and 2017; and March 29 for 2013 and 2019. See Appendix A for changes in the survey base, methods, and instruments that affect analysis of trends over time. Methadone is available only at OTP facilities that are certified by SAMHSA’s Center for Substance Abuse Treatment. Buprenorphine may be prescribed by medical practitioners who have received DATA 2000-specific training and received a waiver to prescribe the medication for treatment of opioid use disorder. Naltrexone may be prescribed by any medical practitioner with prescribing privileges. This report does not include clients who received or were prescribed buprenorphine through an independent DATA 2000-waivered medical practitioner or naltrexone through an independent practitioner not affiliated with a substance abuse treatment facility. Percentages may not sum to 100 percent because of rounding.
SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services (N-SSATS), 2009–2019.

Table 3.1. Clients in treatment, by facility operation: Number and column percent distribution, 2009–2019
	Number of clients						Column percent distribution of clients
Facility operation	2009	2011	2013	2015	2017	2019	2009	2011	2013	2015	2017	2019
Total	1,182,077	1,224,127	1,249,629	1,305,647	1,356,015	1,460,706	100.0	100.0	100.0	100.0	100.0	100.0
Facility operation
Private non-profit	630,579	646,904	638,858	670,593	658,896	726,238	53.3	52.8	51.1	51.4	48.6	49.7
Private for-profit	375,256	395,577	430,362	475,531	550,992	591,442	31.7	32.3	34.4	36.4	40.6	40.5
Local, county, or community govt.	75,126	73,338	72,949	67,060	66,577	59,708	6.4	6.0	5.8	5.1	4.9	4.1
State government	42,761	40,303	35,812	30,675	28,529	27,081	3.6	3.3	2.9	2.3	2.1	1.9
Federal government	46,282	47,742	53,695	46,721	34,435	41,848	3.9	3.9	4.3	3.6	2.5	2.9
Dept. of Veterans Affairs	37,381	37,321	44,180	39,501	29,619	36,951	3.2	3.0	3.5	3.0	2.2	2.5
Dept. of Defense	6,877	8,487	6,685	5,774	3,618	2,065	0.6	0.7	0.5	0.4	0.3	0.1
Indian Health Service	1,982	1,838	1,368	1,218	1,103	842	0.2	0.2	0.1	0.1	0.1	0.1
Other	42	96	1,462	228	95	1,990	*	*	0.1	*	*	0.1
Tribal government	12,073	20,263	17,953	15,067	16,586	14,389	1.0	1.7	1.4	1.2	1.2	1.0
* Less than 0.05 percent.
NOTES: Survey reference dates were March 31 for 2009, 2011, 2015, and 2017; and March 29 for 2013 and 2019. See Appendix A for changes in the survey base, methods, and instruments that affect analysis of trends over time. Percentages may not sum to 100 percent because of rounding.
SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services (N-SSATS), 2009–2019.

Table 3.2. Clients in treatment, by type of care received, and clients receiving buprenorphine, naltrexone, or methadone: Number and column percent distribution, 2009–2019
Type of care received and clients receiving buprenorphine, naltrexone, or methadone	Number of clients						Column percent distribution of clients
	2009	2011	2013	2015	2017	2019	2009	2011	2013	2015	2017	2019
Total	1,182,077	1,224,127	1,249,629	1,305,647	1,356,015	1,460,706	100.0	100.0	100.0	100.0	100.0	100.0
Type of care received
Outpatient	1,064,562	1,095,897	1,127,235	1,161,456	1,238,654	1,355,024	90.1	89.5	90.2	89.0	91.3	92.8
Regular	598,282	617,715	603,315	604,819	599,290	642,554	50.6	50.5	48.3	46.3	44.2	44.0
Intensive	147,132	141,964	147,162	128,536	133,850	130,343	12.4	11.6	11.8	9.8	9.9	8.9
Detoxification	10,786	13,450	13,839	14,457	11,839	21,460	0.9	1.1	1.1	1.1	0.9	1.5
Day treatment/partial hospitalization	23,822	23,338	22,828	23,138	23,310	19,973	2.0	1.9	1.8	1.8	1.7	1.4
Methadone/buprenorphine maintenance or naltrexone treatment	284,540	299,430	340,091	390,506	470,365	540,694	24.1	24.5	27.2	29.9	34.7	37.0
Residential (non-hospital)	103,174	112,827	107,727	119,900	99,881	91,592	8.7	9.2	8.6	9.2	7.4	6.3
Detoxification	6,067	9,326	10,244	13,748	10,938	8,629	0.5	0.8	0.8	1.1	0.8	0.6
Short-term treatment (30 days or fewer)	25,807	29,164	27,184	36,651	32,156	33,698	2.2	2.4	2.2	2.8	2.4	2.3
Long-term treatment (more than 30 days)	71,300	74,337	70,299	69,501	56,787	49,265	6.0	6.1	5.6	5.3	4.2	3.4
Hospital inpatient	14,341	15,403	14,667	24,291	17,480	14,090	1.2	1.3	1.2	1.9	1.3	1.0
Detoxification	6,427	6,179	5,768	12,394	7,551	6,258	0.5	0.5	0.5	0.9	0.6	0.4
Treatment	7,914	9,224	8,899	11,897	9,929	7,832	0.7	0.8	0.7	0.9	0.7	0.5
Clients receiving buprenorphine or naltrexone
Clients receiving buprenorphine	24,173	32,676	48,148	75,724	112,223	168,428	2.0	2.7	3.9	5.8	8.3	11.5
Clients receiving naltrexone	n/a	n/a	3,781	7,035	23,065	30,394	n/a	n/a	0.3	0.5	1.7	2.1
Clients receiving methadone (OTP facilities only)
Clients receiving methadone	283,177	306,440	330,308	356,843	382,867	408,550	24.0	25.0	26.4	27.3	28.2	28.0
n/a Not applicable.
NOTES: Survey reference dates were March 31 for 2009, 2011, 2015, and 2017; and March 29 for 2013 and 2019. See Appendix A for changes in the survey base, methods, and instruments that affect analysis of trends over time. Methadone is available only at OTP facilities that are certified by SAMHSA’s Center for Substance Abuse Treatment. Buprenorphine may be prescribed by medical practitioners who have received DATA 2000-specific training and received a waiver to prescribe the medication for treatment of opioid use disorder. Naltrexone may be prescribed by any medical practitioner with prescribing privileges. This report does not include clients who were prescribed buprenorphine through an independent DATA 2000-waivered medical practitioner or naltrexone through an independent practitioner not affiliated with a substance abuse treatment facility.
SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services (N-SSATS), 2009–2019.

Table 3.3. Clients in treatment, by substance abuse problem and diagnosed co-occurring mental and substance use disorders: Number and column percent distribution, 2009–2019
Substance abuse problem and diagnosed co-occurring mental and substance use disorders	Number of clients						Column percent distribution of clients
	2009	2011	2013	2015	2017	2019	2009	2011	2013	2015	2017	2019
Total¹	1,182,077	1,224,127	1,249,629	1,305,647	1,356,015	1,460,706	100.0	100.0	100.0	100.0	100.0	100.0
Substance abuse problem
Clients with both alcohol and drug abuse	517,887	535,258	534,078	520,866	500,948	476,065	43.8	43.7	42.7	39.9	36.9	32.6
Clients with drug abuse only	441,128	464,406	491,903	531,963	642,713	743,828	37.3	37.9	39.4	40.7	47.4	50.9
Clients with alcohol abuse only	220,373	221,632	216,856	200,187	211,460	205,402	18.6	18.1	17.4	15.3	15.6	14.1
Diagnosed co-occurring mental and substance use disorders	456,567	506,162	563,071	614,789	683,810	702,914	38.6	41.3	45.1	47.1	50.4	48.1
¹ Totals include clients in facilities that did not respond to the substance abuse problem question (in 2009, 2,690 clients reported by 152 facilities; in 2011, 2,832 clients reported by 188 facilities; in 2013, 6,792 clients reported by 257 facilities; in 2015, 725 clients reported by 235 facilities; in 2017, 894 clients reported by 279 facilities; and in 2019, 35,412 clients reported by 522 facilities).
NOTES: Survey reference dates were: March 31 for 2009, 2011, 2015, and 2017; and March 29 for 2013 and 2019. See Appendix A for changes in the survey base, methods, and instruments that affect analysis of trends over time. Numbers may not sum to totals and percentages may not sum to 100 percent because of rounding.
SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services (N-SSATS), 2009–2019.

Table 3.4. Clients under the age of 18 years in treatment, by type of care received, and clients under the age of 18 years in treatment in facilities offering special programs or groups for adolescents: Number and column percent distribution, 2009–2019
Type of care received and clients under the age of 18 years in facilities with special programs or groups for adolescents	Number of clients under the age of 18 years¹						Column percent distribution of clients under the age of 18 years
	2009	2011	2013	2015	2017	2019	2009	2011	2013	2015	2017	2019
Total¹	84,326	82,532	78,156	72,977	62,862	59,854	100.0	100.0	100.0	100.0	100.0	100.0
Type of care received
Outpatient	74,623	71,687	69,184	63,493	55,613	53,636	88.5	86.9	88.5	87.0	88.5	89.6
Residential (non-hospital)	8,947	9,738	8,071	7,807	6,539	5,468	10.6	11.8	10.3	10.7	10.4	9.1
Hospital inpatient	756	1,107	901	1,677	710	750	0.9	1.3	1.2	2.3	1.1	1.3
Clients under the age of 18 years in facilities with special programs or groups for adolescents	68,448	65,918	65,276	54,650	46,253	43,996	81.2	79.9	83.5	74.9	73.6	73.5
¹ The total number of clients excludes the clients in the facilities that did not respond to the question about clients under the age of 18 years (in 2009, 346 total clients reported by five facilities; in 2011, 1,417 total clients reported by nine facilities; in 2013, 2,520 clients reported by 19 facilities; in 2015, 41 clients reported by one facility; and in 2017, 62 clients reported by two facilities; and in 2019, 4,684 total clients reported by 37 facilities).
NOTES: Survey reference dates were: March 31 for 2009, 2011, 2015, and 2017; and March 29 for 2013 and 2019. See Appendix A for changes in the survey base, methods, and instruments that affect analysis of trends over time. Percentages may not sum to 100 percent because of rounding.
SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services (N-SSATS), 2009–2019.

Table 4.1a. Type of care offered, by facility operation: Number, 2019
Facility operation		Type of care offered
			Outpatient						Residential (non-hospital)				Hospital inpatient
	Total¹	Any out-patient	Regular	Intensive	Day treatment or partial hospitali-zation	Detox	Methadone/ buprenorphine maintenance or naltrexone treatment	Any residen- tial	Short-term	Long-term	Detox	Any hospital inpatient	Treat-ment	Detox
Total	15,961	13,044	12,114	7,325	2,255	1,752	5,256	3,794	2,386	2,958	1,410	898	680	806
Facility operation
Private non-profit	8,043	6,164	5,880	3,543	884	584	2,286	2,367	1,225	1,935	583	374	269	328
Private for-profit	6,327	5,480	4,875	3,052	1,233	977	2,379	1,139	985	824	737	380	319	357
Local, county, or community govt.	694	622	603	320	42	36	216	74	42	45	36	41	26	36
State government	310	220	206	104	35	26	87	90	46	60	17	42	34	25
Federal government	333	320	315	183	44	118	223	94	77	66	35	60	32	59
Dept. of Veterans Affairs	222	214	212	152	35	110	196	84	71	58	33	58	30	57
Dept. of Defense	69	67	67	20	8	5	12	5	4	3	1	1	1	1
Indian Health Service	31	29	28	10	- -	2	8	5	2	5	1	- -	- -	- -
Other	11	10	8	1	1	1	7	- -	- -	- -	- -	1	1	1
Tribal government	254	238	235	123	17	11	65	30	11	28	2	1	- -	1
- - Quantity is zero.
¹ Numbers of facilities sum to more than the total column, because a facility could provide more than one type of care.
NOTES: Methadone is available only at OTP facilities that are certified by SAMHSA’s Center for Substance Abuse Treatment. Buprenorphine may be prescribed by medical practitioners who have received DATA 2000-specific training and received a waiver to prescribe the medication for treatment of opioid use disorder. Naltrexone may be prescribed by any medical practitioner with prescribing privileges. This report does not include clients who received or were prescribed buprenorphine through an independent DATA 2000-waivered medical practitioner or naltrexone through an independent practitioner not affiliated with a substance abuse treatment facility.
SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services (N-SSATS), 2019.

Table 4.1b. Type of care offered, by facility operation: Row percent, 2019
Facility operation		Type of care offered
			Outpatient						Residential (non-hospital)				Hospital inpatient
	Number of facilities¹	Any out-patient	Regular	Intensive	Day treatment or partial hospitali-zation	Detox	Methadone/ buprenorphine maintenance or naltrexone treatment	Any residen- tial	Short-term	Long-term	Detox	Any hospital inpatient	Treat-ment	Detox
Total	15,961	81.7	75.9	45.9	14.1	11.0	32.9	23.8	14.9	18.5	8.8	5.6	4.3	5.0
Facility operation
Private non-profit	8,043	76.6	73.1	44.1	11.0	7.3	28.4	29.4	15.2	24.1	7.2	4.7	3.3	4.1
Private for-profit	6,327	86.6	77.1	48.2	19.5	15.4	37.6	18.0	15.6	13.0	11.6	6.0	5.0	5.6
Local, county, or community govt.	694	89.6	86.9	46.1	6.1	5.2	31.1	10.7	6.1	6.5	5.2	5.9	3.7	5.2
State government	310	71.0	66.5	33.5	11.3	8.4	28.1	29.0	14.8	19.4	5.5	13.5	11.0	8.1
Federal government	333	96.1	94.6	55.0	13.2	35.4	67.0	28.2	23.1	19.8	10.5	18.0	9.6	17.7
Dept. of Veterans Affairs	222	96.4	95.5	68.5	15.8	49.5	88.3	37.8	32.0	26.1	14.9	26.1	13.5	25.7
Dept. of Defense	69	97.1	97.1	29.0	11.6	7.2	17.4	7.2	5.8	4.3	1.4	1.4	1.4	1.4
Indian Health Service	31	93.5	90.3	32.3	- -	6.5	25.8	16.1	6.5	16.1	3.2	- -	- -	- -
Other	11	90.9	72.7	9.1	9.1	9.1	63.6	- -	- -	- -	- -	9.1	9.1	9.1
Tribal government	254	93.7	92.5	48.4	6.7	4.3	25.6	11.8	4.3	11.0	0.8	0.4	- -	0.4
- - Quantity is zero.
¹ Percentages sum to more than 100 percent, because a facility could provide more than one type of care.
NOTES: Methadone is available only at OTP facilities that are certified by SAMHSA’s Center for Substance Abuse Treatment. Buprenorphine may be prescribed by medical practitioners who have received DATA 2000-specific training and received a waiver to prescribe the medication for treatment of opioid use disorder. Naltrexone may be prescribed by any medical practitioner with prescribing privileges. This report does not include clients who received or were prescribed buprenorphine through an independent DATA 2000-waivered medical practitioner or naltrexone through an independent practitioner not affiliated with a substance abuse treatment facility.
SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services (N-SSATS), 2019.

Table 4.2. Type of substance abuse problem treated and treatment of clients with diagnosed co-occurring mental and substance use disorders, by facility operation: Number and row percent, March 29, 2019
Facility operation	Number of facilities^1,2					Row percent of facilities¹
	Total²	Client substance abuse problem			Treats clients with diagnosed co-occurring mental and substance use disorders	Client substance abuse problem			Treats clients with diagnosed co-occurring mental and substance use disorders
	Total²	Treats clients with both alcohol and drug abuse	Treats clients with drug abuse only	Treats clients with alcohol abuse only		Treats clients with both alcohol and drug abuse	Treats clients with drug abuse only	Treats clients with alcohol abuse only
Total	11,773	10,414	10,192	9,123	10,503	88.5	86.6	77.5	89.2
Facility operation
Private non-profit	5,867	5,431	5,130	4,745	5,345	92.6	87.4	80.9	91.1
Private for-profit	4,735	3,903	4,053	3,380	4,068	82.4	85.6	71.4	85.9
Local, county, or community govt.	500	468	457	423	459	93.6	91.4	84.6	91.8
State government	238	217	196	180	225	91.2	82.4	75.6	94.5
Federal government	256	224	212	243	246	87.5	82.8	94.9	96.1
Dept. of Veterans Affairs	175	171	165	166	175	97.7	94.3	94.9	100.0
Dept. of Defense	56	29	25	55	47	51.8	44.6	98.2	83.9
Indian Health Service	19	18	18	17	18	94.7	94.7	89.5	94.7
Other	6	6	4	5	6	100.0	66.7	83.3	100.0
Tribal government	177	171	144	152	160	96.6	81.4	85.9	90.4
¹ Number of facilities sums to more than the total column, and percentages sum to more than 100 percent, because a facility could treat more than one type of client substance abuse problem.
² Of 15,961 facilities, 4,188 facilities (26 percent) did not respond to the questions on client substance abuse problem and diagnosed co-occurring mental and substance use disorders; percentages are based on the remaining 11,773 facilities.
SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services (N-SSATS), 2019.

Table 4.3. Facility size, by type of care offered and facility operation at facilities with opioid treatment programs (OTPs): Median number of clients per facility, March 29, 2019
Facility operation		Type of care offered
			Outpatient						Residential (non-hospital)				Hospital inpatient
	All facilities¹	Total out-patient	Regular	Intensive	Day treatment or partial hospitali-zation	Detox	Methadone/ buprenorphine maintenance or naltrexone treatment	Total residen- tial	Short- term	Long- term	Detox	Total hospital inpatient	Treatment	Detox
Total	261	284	60	20	11	5	261	35	29	36	15	20	20	15
Facility operation
Private non-profit	285	323	56	24	10	5	289	32	21	36	14	19	16	13
Private for-profit	257	263	60	10	11	5	260	54	41	44	16	26	37	15
Local, county, or community govt.	236	289	148	58	50	5	261	27	23	- -	9	20	18	16
State government	219	288	50	20	- -	2	239	37	26	20	25	37	37	22
Federal government	261	280	100	30	23	5	110	19	16	35	6	5	3	4
Dept. of Veterans Affairs	261	280	100	30	23	5	110	19	16	35	6	5	3	4
Dept. of Defense	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Indian Health Service	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Other	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Tribal government	525	525	150	122	- -	- -	190	- -	- -	- -	- -	- -	- -	- -
- - Quantity is zero; ‡ No facilities in this category.
¹ Of 1,691 OTP facilities, 232 facilities (14 percent) whose client counts were reported by another facility were not asked to respond to these questions. Of the remaining 1,459 OTP facilities, 29 facilities (2 percent) that included client counts for other facilities were excluded from tabulations for this table, and thus, tabulations are based on 1,430 OTP facilities that reported client counts for their facility alone.
NOTES: Methadone is available only at OTP facilities that are certified by SAMHSA’s Center for Substance Abuse Treatment. Buprenorphine may be prescribed by medical practitioners who have received DATA 2000-specific training and received a waiver to prescribe the medication for treatment of opioid use disorder. Naltrexone may be prescribed by any medical practitioner with prescribing privileges. This report does not include clients who received or were prescribed buprenorphine through an independent DATA 2000-waivered medical practitioner or naltrexone through an independent practitioner not affiliated with a substance abuse treatment facility.
SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services(N-SSATS), 2019.

Table 4.4. Facility size, by type of care offered and facility operation at facilities without opioid treatment programs (non-OTPs): Median number of clients per facility, March 29, 2019
Facility operation		Type of care offered
			Outpatient						Residential (non-hospital)				Hospital inpatient
	All facilities¹	Total out-patient	Regular	Intensive	Day treat- ment or partial hospitali-zation	Detox	Methadone/ buprenorphine maintenance or naltrexone treatment	Total residential	Short- term	Long- term	Detox	Total hospital inpatient	Treatment	Detox
Total	35	40	30	15	10	5	20	17	12	15	5	12	11	6
Facility operation
Private non-profit	37	47	36	16	10	6	17	19	15	16	6	12	12	6
Private for-profit	30	32	21	12	9	5	22	13	8	11	4	13	10	7
Local, county, or community govt.	50	61	48	15	10	5	17	18	16	17	9	12	10	3
State government	36	47	32	22	14	8	37	16	16	15	10	13	20	6
Federal government	68	57	33	15	11	3	30	24	18	15	7	5	15	4
Dept. of Veterans Affairs	113	89	55	15	12	4	31	25	18	17	11	5	17	4
Dept. of Defense	19	17	14	9	10	2	12	42	- -	42	- -	16	15	1
Indian Health Service	22	24	15	13	- -	6	3	8	1	8	1	- -	- -	- -
Other	168	300	150	25	- -	25	100	- -	- -	- -	- -	20	10	10
Tribal government	28	33	25	11	4	10	18	12	13	11	120	- -	- -	- -
- - Quantity is zero.
¹ Of 14,270 non-OTP facilities, 3,441 facilities (24 percent) whose client counts were reported by another facility were not asked to respond to these questions. Of the remaining 10,829 non-OTP facilities, 441 facilities (4 percent) that included client counts for other facilities were excluded from tabulations for this table, and thus, tabulations are based on 10,388 facilities that reported client counts for their facility alone.
NOTES: Methadone is available only at OTP facilities that are certified by SAMHSA’s Center for Substance Abuse Treatment. Buprenorphine may be prescribed by medical practitioners who have received DATA 2000-specific training and received a waiver to prescribe the medication for treatment of opioid use disorder. Naltrexone may be prescribed by any medical practitioner with prescribing privileges. This report does not include clients who received or were prescribed buprenorphine through an independent DATA 2000-waivered medical practitioner or naltrexone through an independent practitioner not affiliated with a substance abuse treatment facility.
SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services (N-SSATS), 2019.

Table 4.5a. Facility size in terms of number of clients in outpatient treatment, by facility operation: Number and row percent distribution, March 29, 2019
Facility operation	Number of facilities						Row percent distribution of facilities
Facility operation	Total	Fewer than 15 clients	15–29 clients	30–59 clients	60–119 clients	120 clients or more	Total	Fewer than 15 clients	15–29 clients	30–59 clients	60–119 clients	120 clients or more
Total	11,005	2,419	1,650	1,880	1,969	3,087	100.0	22.0	15.0	17.1	17.9	28.1
Facility operation
Private non-profit	5,182	1,082	731	950	1,010	1,409	100.0	20.9	14.1	18.3	19.5	27.2
Private for-profit	4,680	1,104	754	748	724	1,350	100.0	23.6	16.1	16.0	15.5	28.8
Local, county, or community govt.	523	83	79	77	127	157	100.0	15.9	15.1	14.7	24.3	30.0
State government	183	39	24	38	28	54	100.0	21.3	13.1	20.8	15.3	29.5
Federal government	262	60	30	35	46	91	100.0	22.9	11.5	13.4	17.6	34.7
Dept. of Veterans Affairs	176	22	15	22	35	82	100.0	12.5	8.5	12.5	19.9	46.6
Dept. of Defense	60	27	12	8	9	4	100.0	45.0	20.0	13.3	15.0	6.7
Indian Health Service	20	9	3	4	2	2	100.0	45.0	15.0	20.0	10.0	10.0
Other	6	2	- -	1	- -	3	100.0	33.3	- -	16.7	- -	50.0
Tribal government	175	51	32	32	34	26	100.0	29.1	18.3	18.3	19.4	14.9
- - Quantity is zero.



NOTE: Percentages may not sum to 100 percent because of rounding.
SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services (N-SSATS), 2019.

Table 4.5b. Facility size in terms of number of clients in residential (non-hospital) treatment, by facility operation: Number and row percent distribution, March 29, 2019
Facility operation	Number of facilities						Row percent distribution of facilities
Facility operation	Total	Fewer than 15 clients	15–29 clients	30–59 clients	60–119 clients	120 clients or more	Total	Fewer than 15 clients	15–29 clients	30–59 clients	60–119 clients	120 clients or more
Total	3,154	1,364	912	542	250	86	100.0	43.2	28.9	17.2	7.9	2.7
Facility operation
Private non-profit	2,007	764	646	371	173	53	100.0	38.1	32.2	18.5	8.6	2.6
Private for-profit	895	508	181	122	59	25	100.0	56.8	20.2	13.6	6.6	2.8
Local, county, or community govt.	68	24	22	17	5	- -	100.0	35.3	32.4	25.0	7.4	- -
State government	81	31	25	19	3	3	100.0	38.3	30.9	23.5	3.7	3.7
Federal government	77	21	30	13	9	4	100.0	27.3	39.0	16.9	11.7	5.2
Dept. of Veterans Affairs	71	16	30	13	8	4	100.0	22.5	42.3	18.3	11.3	5.6
Dept. of Defense	3	2	- -	- -	1	- -	100.0	66.7	- -	- -	33.3	- -
Indian Health Service	3	3	- -	- -	- -	- -	100.0	100.0	- -	- -	- -	- -
Other	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Tribal government	26	16	8	- -	1	1	100.0	61.5	30.8	- -	3.8	3.8
- - Quantity is zero; ‡ No facilities in this category.
NOTE: Percentages may not sum to 100 percent because of rounding.
SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services (N-SSATS), 2019.

Table 4.5c. Facility size in terms of number of clients in hospital inpatient treatment, by facility operation: Number and row percent distribution, March 29, 2019
Facility operation	Number of facilities						Row percent distribution of facilities
Facility operation	Total	Fewer than 15 clients	15–29 clients	30–59 clients	60–119 clients	120 clients or more	Total	Fewer than 15 clients	15–29 clients	30–59 clients	60–119 clients	120 clients or more
Total	680	399	153	72	44	12	100.0	58.7	22.5	10.6	6.5	1.8
Facility operation
Private non-profit	293	174	76	32	9	2	100.0	59.4	25.9	10.9	3.1	0.7
Private for-profit	273	153	53	28	30	9	100.0	56.0	19.4	10.3	11.0	3.3
Local, county, or community govt.	32	17	11	4	- -	- -	100.0	53.1	34.4	12.5	- -	- -
State government	33	17	6	7	3	- -	100.0	51.5	18.2	21.2	9.1	- -
Federal government	48	37	7	1	2	1	100.0	77.1	14.6	2.1	4.2	2.1
Dept. of Veterans Affairs	46	37	5	1	2	1	100.0	80.4	10.9	2.2	4.3	2.2
Dept. of Defense	1	- -	1	- -	- -	- -	100.0	- -	100.0	- -	- -	- -
Indian Health Service	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Other	1	- -	1	- -	- -	- -	100.0	- -	100.0	- -	- -	- -
Tribal government	1	1	- -	- -	- -	- -	100.0	100.0	- -	- -	- -	- -
- - Quantity is zero; ‡ No facilities in this category.
NOTE: Percentages may not sum to 100 percent because of rounding.
SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services (N-SSATS), 2019.

Table 4.6. Facility capacity and utilization of residential (non-hospital) care, by facility operation: Number, utilization rate, and row percent distribution, March 29, 2019
			Designated beds per facility¹	Number of facilities					Row percent distribution of facilities
					Utilization rate¹					Utilization rate¹
Facility operation	Designated beds¹	Overall utilization rate (%)^1,2		Total	50% or less	51– 90%	91– 100%	More than 100%	Total	50% or less	51– 90%	91– 100%	More than 100%
Total	88,447	94.8	33	2,710	335	1,011	1,078	286	100.0	12.4	37.3	39.8	10.6
Facility operation
Private non-profit	59,713	93.7	34	1,770	176	690	750	154	100.0	9.9	39.0	42.4	8.7
Private for-profit	22,044	94.8	31	721	145	223	245	108	100.0	20.1	30.9	34.0	15.0
Local, county, or community govt.	1,892	79.3	34	55	3	34	15	3	100.0	5.5	61.8	27.3	5.5
State government	2,289	97.7	31	75	6	25	39	5	100.0	8.0	33.3	52.0	6.7
Federal government	2,171	125.7	33	66	2	29	23	12	100.0	3.0	43.9	34.8	18.2
Dept. of Veterans Affairs	2,046	128.2	34	61	1	28	20	12	100.0	1.6	45.9	32.8	19.7
Dept. of Defense	97	86.6	49	2	1	- -	1	- -	100.0	50.0	- -	50.0	- -
Indian Health Service	28	82.1	9	3	- -	1	2	- -	100.0	- -	33.3	66.7	- -
Other	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Tribal government	338	175.7	15	23	3	10	6	4	100.0	13.0	43.5	26.1	17.4
- - Quantity is zero; ‡ No facilities in this category.
¹ The number of designated beds, overall utilization rate, and designated beds per facility are based on 2,710 facilities (88,447 designated beds and 83,877 clients) that reported offering residential (non-hospital) services and reported both designated beds and clients for their facility alone.
² The utilization rates may be more than 100 percent, because the substance abuse treatment clients may also occupy non-designated beds.
NOTE: Percentages may not sum to 100 percent because of rounding.
SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services (N-SSATS), 2019.

Table 4.7. Facility capacity and utilization of hospital inpatient care, by facility operation: Number, utilization rate, and row percent distribution, March 29, 2019
Facility operation	Designated beds¹	Overall utilization rate (%)^1,2	Designated beds per facility¹	Number of facilities					Row percent distribution of facilities
				Total	Utilization rate¹				Total	Utilization rate¹
				Total	50% or less	51– 90%	91– 100%	More than 100%	Total	50% or less	51– 90%	91– 100%	More than 100%
Total	13,023	87.1	28	459	104	174	102	79	100.0	22.7	37.9	22.2	17.2
Facility operation
Private non-profit	4,774	79.3	24	196	32	85	53	26	100.0	16.3	43.4	27.0	13.3
Private for-profit	6,824	91.1	33	205	59	69	36	41	100.0	28.8	33.7	17.6	20.0
Local, county, or community govt.	482	87.8	19	25	6	8	5	6	100.0	24.0	32.0	20.0	24.0
State government	772	80.1	35	22	5	10	5	2	100.0	22.7	45.5	22.7	9.1
Federal government	171	176.0	16	11	2	2	3	4	100.0	18.2	18.2	27.3	36.4
Dept. of Veterans Affairs	137	193.4	15	9	2	1	3	3	100.0	22.2	11.1	33.3	33.3
Dept. of Defense	20	80.0	20	1	- -	1	- -	- -	100.0	- -	100.0	- -	- -
Indian Health Service	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Other	14	142.9	14	1	- -	- -	- -	1	100.0	- -	- -	- -	100.0
Tribal government	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
- - Quantity is zero; ‡ No facilities in this category.
¹ The number of designated beds, overall utilization rate, and designated beds per facility are based on 459 facilities (13,023 designated beds and 11,344 clients) that reported offering hospital inpatient services and reported both designated beds and clients for their facility alone.
² The utilization rates may be more than 100 percent, because the substance abuse treatment clients may also occupy non-designated beds.
NOTE: Percentages may not sum to 100 percent because of rounding.
SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services (N-SSATS), 2019.

Table 4.8a. Services provided, by facility operation: Number and column percent, 2019
Services	Number of facilities							Column percent of facilities
	Total	Facility operation						Total	Facility operation
	Total	Private non-profit	Private for-profit	Local, county, or community govt.	State govt.	Federal govt.	Tribal govt.	Total	Private non-profit	Private for-profit	Local, county, or community govt.	State govt.	Federal govt.	Tribal govt.
Total	15,961	8,043	6,327	694	310	333	254
Assessment and pre-treatment services	15,794	7,946	6,265	689	309	332	253	99.0	98.8	99.0	99.3	99.7	99.7	99.6
Screening for substance abuse	15,443	7,735	6,179	671	296	311	251	96.8	96.2	97.7	96.7	95.5	93.4	98.8
Screening for mental disorders	12,351	6,505	4,489	585	259	292	221	77.4	80.9	70.9	84.3	83.5	87.7	87.0
Comprehensive substance abuse assessment or diagnosis	14,961	7,474	5,974	667	293	315	238	93.7	92.9	94.4	96.1	94.5	94.6	93.7
Comprehensive mental health assessment or diagnosis	8,964	4,665	3,217	447	211	270	154	56.2	58.0	50.8	64.4	68.1	81.1	60.6
Screening for tobacco use	11,564	6,202	4,081	526	246	310	199	72.5	77.1	64.5	75.8	79.4	93.1	78.3
Outreach to persons in community who may need treatment	10,282	5,391	3,760	515	189	213	214	64.4	67.0	59.4	74.2	61.0	64.0	84.3
Interim services for clients when immediate admission is not possible	7,659	4,150	2,404	487	179	250	189	48.0	51.6	38.0	70.2	57.7	75.1	74.4
Professional interventionist/educational consultant	2,900	1,198	1,417	104	47	76	58	18.2	14.9	22.4	15.0	15.2	22.8	22.8
Testing	14,515	7,328	5,721	628	294	322	222	90.9	91.1	90.4	90.5	94.8	96.7	87.4
Drug and alcohol oral fluid testing	4,136	1,905	1,869	188	55	50	69	25.9	23.7	29.5	27.1	17.7	15.0	27.2
Breathalyzer or other blood alcohol testing	10,232	4,965	4,244	432	188	274	129	64.1	61.7	67.1	62.2	60.6	82.3	50.8
Drug or alcohol urine screening	13,993	7,076	5,544	590	285	297	201	87.7	88.0	87.6	85.0	91.9	89.2	79.1
Testing for hepatitis B (HBV)	4,288	1,941	1,708	169	121	248	101	26.9	24.1	27.0	24.4	39.0	74.5	39.8
Testing for hepatitis C (HCV)	4,881	2,250	1,941	187	135	253	115	30.6	28.0	30.7	26.9	43.5	76.0	45.3
HIV testing	5,004	2,443	1,810	203	181	261	106	31.4	30.4	28.6	29.3	58.4	78.4	41.7
STD testing	4,092	1,844	1,626	141	134	246	101	25.6	22.9	25.7	20.3	43.2	73.9	39.8
TB screening	6,650	3,247	2,554	280	201	251	117	41.7	40.4	40.4	40.3	64.8	75.4	46.1
Testing for metabolic syndrome	1,288	601	431	81	36	102	37	8.1	7.5	6.8	11.7	11.6	30.6	14.6
Medical services	1,657	881	325	94	52	225	80	10.4	11.0	5.1	13.5	16.8	67.6	31.5
Hepatitis A (HAV) vaccination	1,533	820	290	88	49	212	74	9.6	10.2	4.6	12.7	15.8	63.7	29.1
Hepatitis B (HBV) vaccination	1,510	795	282	89	47	220	77	9.5	9.9	4.5	12.8	15.2	66.1	30.3
Transitional services	15,763	7,971	6,217	692	304	329	250	98.8	99.1	98.3	99.7	98.1	98.8	98.4
Discharge planning	15,229	7,764	5,954	678	300	296	237	95.4	96.5	94.1	97.7	96.8	88.9	93.3
Aftercare/continuing care	13,865	7,020	5,474	588	238	307	238	86.9	87.3	86.5	84.7	76.8	92.2	93.7
Naloxone and overdose education	8,007	4,114	2,977	374	168	247	127	50.2	51.2	47.1	53.9	54.2	74.2	50.0
Outcome follow-up after discharge	10,908	5,536	4,297	445	199	250	181	68.3	68.8	67.9	64.1	64.2	75.1	71.3
Recovery support services	14,070	7,438	5,155	648	291	294	244	88.2	92.5	81.5	93.4	93.9	88.3	96.1
Mentoring/peer support	9,779	5,326	3,427	420	220	227	159	61.3	66.2	54.2	60.5	71.0	68.2	62.6
Self-help groups	7,813	4,045	2,962	275	167	190	174	49.0	50.3	46.8	39.6	53.9	57.1	68.5
Assistance in locating housing for clients	9,764	5,379	3,291	486	220	231	157	61.2	66.9	52.0	70.0	71.0	69.4	61.8
Employment counseling or training for clients	6,857	3,874	2,250	307	152	191	83	43.0	48.2	35.6	44.2	49.0	57.4	32.7
Assistance with obtaining social services (for example, Medicaid, WIC, SSI, SSDI)	10,546	6,070	3,260	557	245	212	202	66.1	75.5	51.5	80.3	79.0	63.7	79.5
Recovery coach	3,613	1,929	1,360	139	61	61	63	22.6	24.0	21.5	20.0	19.7	18.3	24.8
Education and counseling services	15,878	8,023	6,266	694	310	331	254	99.5	99.8	99.0	100.0	100.0	99.4	100.0
HIV or AIDS education, counseling, or support	9,326	4,970	3,304	434	237	231	150	58.4	61.8	52.2	62.5	76.5	69.4	59.1
Hepatitis education, counseling, or support	8,427	4,419	3,043	375	208	241	141	52.8	54.9	48.1	54.0	67.1	72.4	55.5
Health education other than HIV/AIDS or hepatitis	9,067	4,905	3,121	410	229	246	156	56.8	61.0	49.3	59.1	73.9	73.9	61.4
Substance abuse education	15,482	7,823	6,100	682	307	319	251	97.0	97.3	96.4	98.3	99.0	95.8	98.8
Smoking/tobacco cessation counseling	9,148	4,856	3,217	422	225	280	148	57.3	60.4	50.8	60.8	72.6	84.1	58.3
Individual counseling	15,445	7,883	6,009	684	308	308	253	96.8	98.0	95.0	98.6	99.4	92.5	99.6
Group counseling	14,850	7,671	5,688	658	298	303	232	93.0	95.4	89.9	94.8	96.1	91.0	91.3
Family counseling	12,970	6,634	5,055	569	250	244	218	81.3	82.5	79.9	82.0	80.6	73.3	85.8
Marital/couples counseling	9,564	4,623	4,026	339	147	248	181	59.9	57.5	63.6	48.8	47.4	74.5	71.3
Vocational training or educational support	2,488	1,476	700	97	60	110	45	15.6	18.4	11.1	14.0	19.4	33.0	17.7
Ancillary services	15,376	7,855	5,954	684	305	325	253	96.3	97.7	94.1	98.6	98.4	97.6	99.6
Case management services	13,201	6,961	4,827	617	270	291	235	82.7	86.5	76.3	88.9	87.1	87.4	92.5
Social skills development	11,981	6,384	4,356	532	254	256	199	75.1	79.4	68.8	76.7	81.9	76.9	78.3
Child care for clients' children	936	683	112	76	34	9	22	5.9	8.5	1.8	11.0	11.0	2.7	8.7
Domestic violence—family or partner violence services (physical, sexual, and emotional abuse)	6,107	3,140	2,258	225	124	193	167	38.3	39.0	35.7	32.4	40.0	58.0	65.7
Early intervention for HIV	3,670	2,071	1,069	190	121	151	68	23.0	25.7	16.9	27.4	39.0	45.3	26.8
Transportation assistance to treatment	7,376	4,274	2,111	420	167	189	215	46.2	53.1	33.4	60.5	53.9	56.8	84.6
Mental health services	11,102	5,914	3,908	541	244	293	202	69.6	73.5	61.8	78.0	78.7	88.0	79.5
Acupuncture	977	359	428	38	15	97	40	6.1	4.5	6.8	5.5	4.8	29.1	15.7
Residential beds for clients' children	405	357	21	13	12	- -	2	2.5	4.4	0.3	1.9	3.9	- -	0.8
Other services	6,701	3,143	2,841	259	131	171	156	42.0	39.1	44.9	37.3	42.3	51.4	61.4
Treatment for gambling disorder	4,153	2,008	1,672	168	90	111	104	26.0	25.0	26.4	24.2	29.0	33.3	40.9
Treatment for Internet use disorder	2,417	974	1,269	65	19	44	46	15.1	12.1	20.1	9.4	6.1	13.2	18.1
Treatment for other addiction disorder (non- substance abuse)	5,519	2,408	2,584	196	86	127	118	34.6	29.9	40.8	28.2	27.7	38.1	46.5
Pharmacotherapies	10,419	5,233	4,008	491	253	289	145	65.3	65.1	63.3	70.7	81.6	86.8	57.1
Disulfiram (Antabuse^®)	3,715	1,712	1,461	151	96	247	48	23.3	21.3	23.1	21.8	31.0	74.2	18.9
Naltrexone (oral)	5,710	2,770	2,264	234	129	253	60	35.8	34.4	35.8	33.7	41.6	76.0	23.6
Naltrexone (extended-release, injectable, for example, Vivitrol^®)	5,594	2,722	2,242	229	110	230	61	35.0	33.8	35.4	33.0	35.5	69.1	24.0
Acamprosate (Campral^®)	3,880	1,840	1,499	175	102	232	32	24.3	22.9	23.7	25.2	32.9	69.7	12.6
Nicotine replacement	5,171	2,723	1,729	224	148	256	91	32.4	33.9	27.3	32.3	47.7	76.9	35.8
Non-nicotine smoking/tobacco cessation medications (for example, bupropion, varenicline)	4,238	2,127	1,486	185	114	254	72	26.6	26.4	23.5	26.7	36.8	76.3	28.3
Medications for psychiatric disorders	7,760	4,271	2,466	425	218	272	108	48.6	53.1	39.0	61.2	70.3	81.7	42.5
Methadone	1,582	486	975	47	34	35	5	9.9	6.0	15.4	6.8	11.0	10.5	2.0
Buprenorphine¹	6,497	2,955	2,915	213	120	233	61	40.7	36.7	46.1	30.7	38.7	70.0	24.0
Buprenorphine with naloxone (for example, Suboxone^®, Bunavail^®, Zubsolv^®, Cassipa^®)	6,183	2,841	2,736	206	116	227	57	38.7	35.3	43.2	29.7	37.4	68.2	22.4
Buprenorphine without naloxone	4,306	1,821	2,118	140	73	120	34	27.0	22.6	33.5	20.2	23.5	36.0	13.4
Buprenorphine sub-dermal implant (Probuphine^®)	538	181	320	18	6	10	3	3.4	2.3	5.1	2.6	1.9	3.0	1.2
Buprenorphine (extended-release, injectable, for example, Sublocade^®)	1,644	614	905	56	23	35	11	10.3	7.6	14.3	8.1	7.4	10.5	4.3
Medications for HIV treatment (for example, antiretroviral medications such as tenofovir, efavirenz, emtricitabine, atazanavir, and lamivudine)	1,301	598	481	37	36	127	22	8.2	7.4	7.6	5.3	11.6	38.1	8.7
Medications for hepatitis C (HCV) treatment (for example, sofosbuvir, ledipasvir, interferon, peginterferon, ribavirin)	1,416	671	500	41	35	138	31	8.9	8.3	7.9	5.9	11.3	41.4	12.2
Lofexidine	648	247	343	20	8	23	7	4.1	3.1	5.4	2.9	2.6	6.9	2.8
Clonidine	3,742	1,691	1,578	167	100	163	43	23.4	21.0	24.9	24.1	32.3	48.9	16.9
- - Quantity is zero.
Injectable naltrexone = extended-release injectable naltrexone.
¹ Buprenorphine total is not the sum of buprenorphine with and without naloxone and sub-dermal implant, because a facility can provide one or more forms of buprenorphine.
NOTES: Methadone is available only at OTP facilities that are certified by SAMHSA’s Center for Substance Abuse Treatment. Buprenorphine may be prescribed by medical practitioners who have received DATA 2000-specific training and received a waiver to prescribe the medication for treatment of opioid use disorder. Naltrexone may be prescribed by any medical practitioner with prescribing privileges. This report does not include clients who were prescribed buprenorphine through an independent DATA 2000-waivered medical practitioner or naltrexone through an independent practitioner not affiliated with a substance abuse treatment facility.
SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services (N-SSATS), 2019.

Table 4.8b. Services provided, by facility type: Number and column percent, 2019
Services	Number of facilities				Column percent of facilities
	Total	Facility type			Total	Facility type
	Total	OTPs	Serving DUI and DWI	Other	Total	OTPs	Serving DUI and DWI	Other
Total	15,961	1,691	3,662	10,608
Assessment and pre-treatment services	15,794	1,677	3,654	10,463	99.0	99.2	99.8	98.6
Screening for substance abuse	15,443	1,663	3,623	10,157	96.8	98.3	98.9	95.7
Screening for mental disorders	12,351	1,027	2,900	8,424	77.4	60.7	79.2	79.4
Comprehensive substance abuse assessment or diagnosis	14,961	1,593	3,576	9,792	93.7	94.2	97.7	92.3
Comprehensive mental health assessment or diagnosis	8,964	563	2,082	6,319	56.2	33.3	56.9	59.6
Screening for tobacco use	11,564	1,260	2,528	7,776	72.5	74.5	69.0	73.3
Outreach to persons in community who may need treatment	10,282	1,134	2,555	6,593	64.4	67.1	69.8	62.2
Interim services for clients when immediate admission is not possible	7,659	571	2,182	4,906	48.0	33.8	59.6	46.2
Professional interventionist/educational consultant	2,900	211	915	1,774	18.2	12.5	25.0	16.7
Testing	14,515	1,690	3,291	9,534	90.9	99.9	89.9	89.9
Drug and alcohol oral fluid testing	4,136	795	1,041	2,300	25.9	47.0	28.4	21.7
Breathalyzer or other blood alcohol testing	10,232	1,426	2,383	6,423	64.1	84.3	65.1	60.5
Drug or alcohol urine screening	13,993	1,677	3,107	9,209	87.7	99.2	84.8	86.8
Testing for hepatitis B (HBV)	4,288	932	503	2,853	26.9	55.1	13.7	26.9
Testing for hepatitis C (HCV)	4,881	1,117	589	3,175	30.6	66.1	16.1	29.9
HIV testing	5,004	1,010	610	3,384	31.4	59.7	16.7	31.9
STD testing	4,092	995	386	2,711	25.6	58.8	10.5	25.6
TB screening	6,650	1,602	849	4,199	41.7	94.7	23.2	39.6
Testing for metabolic syndrome	1,288	179	172	937	8.1	10.6	4.7	8.8
Medical services	1,657	276	179	1,202	10.4	16.3	4.9	11.3
Hepatitis A (HAV) vaccination	1,533	241	171	1,121	9.6	14.3	4.7	10.6
Hepatitis B (HBV) vaccination	1,510	235	165	1,110	9.5	13.9	4.5	10.5
Transitional services	15,763	1,688	3,614	10,461	98.8	99.8	98.7	98.6
Discharge planning	15,229	1,665	3,529	10,035	95.4	98.5	96.4	94.6
Aftercare/continuing care	13,865	1,379	3,395	9,091	86.9	81.5	92.7	85.7
Naloxone and overdose education	8,007	1,272	1,492	5,243	50.2	75.2	40.7	49.4
Outcome follow-up after discharge	10,908	1,343	2,432	7,133	68.3	79.4	66.4	67.2
Recovery support services	14,070	1,550	3,042	9,478	88.2	91.7	83.1	89.3
Mentoring/peer support	9,779	870	2,152	6,757	61.3	51.4	58.8	63.7
Self-help groups	7,813	754	1,487	5,572	49.0	44.6	40.6	52.5
Assistance in locating housing for clients	9,764	1,165	1,933	6,666	61.2	68.9	52.8	62.8
Employment counseling or training for clients	6,857	809	1,463	4,585	43.0	47.8	40.0	43.2
Assistance with obtaining social services (for example, Medicaid, WIC, SSI, SSDI)	10,546	1,274	2,160	7,112	66.1	75.3	59.0	67.0
Recovery coach	3,613	289	963	2,361	22.6	17.1	26.3	22.3
Education and counseling services	15,878	1,690	3,659	10,529	99.5	99.9	99.9	99.3
HIV or AIDS education, counseling, or support	9,326	1,401	1,923	6,002	58.4	82.9	52.5	56.6
Hepatitis education, counseling, or support	8,427	1,418	1,650	5,359	52.8	83.9	45.1	50.5
Health education other than HIV/AIDS or hepatitis	9,067	1,320	1,741	6,006	56.8	78.1	47.5	56.6
Substance abuse education	15,482	1,672	3,611	10,199	97.0	98.9	98.6	96.1
Smoking/tobacco cessation counseling	9,148	1,129	1,867	6,152	57.3	66.8	51.0	58.0
Individual counseling	15,445	1,678	3,618	10,149	96.8	99.2	98.8	95.7
Group counseling	14,850	1,516	3,559	9,775	93.0	89.7	97.2	92.1
Family counseling	12,970	1,160	3,116	8,694	81.3	68.6	85.1	82.0
Marital/couples counseling	9,564	840	2,588	6,136	59.9	49.7	70.7	57.8
Vocational training or educational support	2,488	204	435	1,849	15.6	12.1	11.9	17.4
Ancillary services	15,376	1,626	3,480	10,270	96.3	96.2	95.0	96.8
Case management services	13,201	1,512	2,899	8,790	82.7	89.4	79.2	82.9
Social skills development	11,981	1,220	2,717	8,044	75.1	72.1	74.2	75.8
Child care for clients' children	936	88	190	658	5.9	5.2	5.2	6.2
Domestic violence—family or partner violence services (physical, sexual, and emotional abuse)	6,107	558	1,789	3,760	38.3	33.0	48.9	35.4
Early intervention for HIV	3,670	714	709	2,247	23.0	42.2	19.4	21.2
Transportation assistance to treatment	7,376	692	1,364	5,320	46.2	40.9	37.2	50.2
Mental health services	11,102	771	2,575	7,756	69.6	45.6	70.3	73.1
Acupuncture	977	135	156	686	6.1	8.0	4.3	6.5
Residential beds for clients' children	405	8	18	379	2.5	0.5	0.5	3.6
Other services	6,701	373	2,000	4,328	42.0	22.1	54.6	40.8
Treatment for gambling disorder	4,153	239	1,349	2,565	26.0	14.1	36.8	24.2
Treatment for Internet use disorder	2,417	60	767	1,590	15.1	3.5	20.9	15.0
Treatment for other addiction disorder (non- substance abuse)	5,519	240	1,599	3,680	34.6	14.2	43.7	34.7
Pharmacotherapies	10,419	1,691	1,738	6,990	65.3	100.0	47.5	65.9
Disulfiram (Antabuse^®)	3,715	404	667	2,644	23.3	23.9	18.2	24.9
Naltrexone (oral)	5,710	611	988	4,111	35.8	36.1	27.0	38.8
Naltrexone (extended-release, injectable, for example, Vivitrol^®)	5,594	675	986	3,933	35.0	39.9	26.9	37.1
Acamprosate (Campral^®)	3,880	354	652	2,874	24.3	20.9	17.8	27.1
Nicotine replacement	5,171	466	722	3,983	32.4	27.6	19.7	37.5
Non-nicotine smoking/tobacco cessation medications (for example, bupropion, varenicline)	4,238	357	683	3,198	26.6	21.1	18.7	30.1
Medications for psychiatric disorders	7,760	541	1,411	5,808	48.6	32.0	38.5	54.8
Methadone	1,582	1,582	- -	- -	9.9	93.6	0.0	0.0
Buprenorphine¹	6,497	1,289	1,031	4,177	40.7	76.2	28.2	39.4
Buprenorphine with naloxone (for example, Suboxone^®, Bunavail^®, Zubsolv^®,Cassipa^®)	6,183	1,176	997	4,010	38.7	69.5	27.2	37.8
Buprenorphine without naloxone	4,306	934	657	2,715	27.0	55.2	17.9	25.6
Buprenorphine sub-dermal implant (Probuphine^®)	538	68	95	375	3.4	4.0	2.6	3.5
Buprenorphine (extended-release, injectable, for example, Sublocade^®)	1,644	179	293	1,172	10.3	10.6	8.0	11.0
Medications for HIV treatment (for example, antiretroviral medications such as tenofovir, efavirenz, emtricitabine, atazanavir, and lamivudine)	1,301	135	104	1,062	8.2	8.0	2.8	10.0
Medications for hepatitis C (HCV) treatment (for example, sofosbuvir, ledipasvir, interferon, peginterferon, ribavirin)	1,416	167	131	1,118	8.9	9.9	3.6	10.5
Lofexidine	648	54	95	499	4.1	3.2	2.6	4.7
Clonidine	3,742	299	520	2,923	23.4	17.7	14.2	27.6
- - Quantity is zero.
DUI/DWI = driving under the influence/driving while intoxicated or impaired; Injectable naltrexone = extended-release injectable naltrexone.
¹ Buprenorphine total is not the sum of buprenorphine with and without naloxone and sub-dermal implant, because a facility can provide one or more forms of buprenorphine.
NOTES: Methadone is available only at OTP facilities that are certified by SAMHSA’s Center for Substance Abuse Treatment. Buprenorphine may be prescribed by medical practitioners who have received DATA 2000-specific training and received a waiver to prescribe the medication for treatment of opioid use disorder. Naltrexone may be prescribed by any medical practitioner with prescribing privileges. This report does not include clients who were prescribed buprenorphine through an independent DATA 2000-waivered medical practitioner or naltrexone through an independent practitioner not affiliated with a substance abuse treatment facility.
SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services (N-SSATS), 2019.

Table 4.9a. Services provided, by type of care: Number, 2019
Services	Total	Type of care
Services	Total	Outpatient only	Hospital inpatient only	Residential (non-hospital) only	Outpatient and hospital inpatient	Outpatient and residential (non-hospital)	Residential (non-hospital) and hospital inpatient	All three types of care
Total	15,961	11,596	310	2,476	261	991	131	196
Assessment and pre-treatment services	15,794	11,546	308	2,371	261	983	129	196
Screening for substance abuse	15,443	11,381	292	2,239	256	955	124	196
Screening for mental disorders	12,351	9,139	249	1,642	242	787	114	178
Comprehensive substance abuse assessment or diagnosis	14,961	11,100	261	2,091	245	945	125	194
Comprehensive mental health assessment or diagnosis	8,964	6,659	216	1,029	216	584	97	163
Screening for tobacco use	11,564	8,340	278	1,695	230	745	108	168
Outreach to persons in community who may need treatment	10,282	7,686	148	1,343	171	714	80	140
Interim services for clients when immediate admission is not possible	7,659	5,968	69	789	108	570	45	110
Professional interventionist/educational consultant	2,900	2,128	40	403	43	193	38	55
Testing	14,515	10,220	305	2,426	260	978	130	196
Drug and alcohol oral fluid testing	4,136	3,164	39	584	40	238	32	39
Breathalyzer or other blood alcohol testing	10,232	6,639	249	1,986	241	826	109	182
Drug or alcohol urine screening	13,993	9,759	299	2,385	259	967	128	196
Testing for hepatitis B (HBV)	4,288	2,500	254	715	201	385	82	151
Testing for hepatitis C (HCV)	4,881	2,916	263	828	206	421	89	158
HIV testing	5,004	2,898	261	924	199	466	91	165
STD testing	4,092	2,279	255	731	200	384	89	154
TB screening	6,650	3,906	284	1,329	216	625	112	178
Testing for metabolic syndrome	1,288	806	100	122	99	89	25	47
Medical services	1,657	991	111	228	81	146	30	70
Hepatitis A (HAV) vaccination	1,533	930	89	215	75	132	29	63
Hepatitis B (HBV) vaccination	1,510	919	106	196	76	122	26	65
Transitional services	15,763	11,422	310	2,452	261	991	131	196
Discharge planning	15,229	10,926	310	2,427	261	980	130	195
Aftercare/continuing care	13,865	10,173	217	1,972	248	950	116	189
Naloxone and overdose education	8,007	5,468	183	1,370	162	576	103	145
Outcome follow-up after discharge	10,908	7,443	199	1,988	168	823	115	172
Recovery support services	14,070	9,802	288	2,425	248	983	131	193
Mentoring/peer support	9,779	6,357	156	2,028	148	835	94	161
Self-help groups	7,813	4,122	233	2,088	212	868	114	176
Assistance in locating housing for clients	9,764	6,374	164	1,986	145	830	104	161
Employment counseling or training for clients	6,857	4,534	35	1,449	52	622	56	109
Assistance with obtaining social services (for example, Medicaid, WIC, SSI, SSDI)	10,546	7,265	214	1,895	163	775	85	149
Recovery coach	3,613	2,479	38	619	44	331	40	62
Education and counseling services	15,878	11,552	299	2,450	261	989	131	196
HIV or AIDS education, counseling, or support	9,326	6,218	212	1,746	147	735	110	158
Hepatitis education, counseling, or support	8,427	5,503	213	1,616	140	683	113	159
Health education other than HIV/AIDS or hepatitis	9,067	5,888	227	1,746	177	754	112	163
Substance abuse education	15,482	11,218	289	2,416	250	983	131	195
Smoking/tobacco cessation counseling	9,148	6,210	249	1,541	218	666	102	162
Individual counseling	15,445	11,252	264	2,389	235	981	131	193
Group counseling	14,850	10,636	275	2,384	255	976	130	194
Family counseling	12,970	9,398	203	1,938	230	894	120	187
Marital/couples counseling	9,564	7,312	97	1,154	145	622	88	146
Vocational training or educational support	2,488	1,343	23	747	27	272	26	50
Ancillary services	15,376	11,106	295	2,413	256	981	130	195
Case management services	13,201	9,319	246	2,205	210	925	117	179
Social skills development	11,981	8,303	191	2,166	168	892	104	157
Child care for clients' children	936	550	1	251	4	114	5	11
Domestic violence—family or partner violence services (physical, sexual, and emotional abuse)	6,107	4,494	71	881	89	424	60	88
Early intervention for HIV	3,670	2,279	88	768	64	336	54	81
Transportation assistance to treatment	7,376	4,567	133	1,601	143	697	88	147
Mental health services	11,102	8,079	226	1,525	237	752	112	171
Acupuncture	977	511	12	216	31	145	17	45
Residential beds for clients' children	405	- -	- -	290	- -	104	4	7
Other services	6,701	5,226	59	782	94	403	48	89
Treatment for gambling disorder	4,153	3,237	32	473	62	249	34	66
Treatment for Internet use disorder	2,417	1,949	8	251	31	131	17	30
Treatment for other addiction disorder (non- substance abuse)	5,519	4,361	43	618	77	313	37	70
Pharmacotherapies	10,419	7,193	309	1,586	261	753	126	191
Disulfiram (Antabuse^®)	3,715	2,394	140	535	169	299	60	118
Naltrexone (oral)	5,710	3,579	184	962	213	500	104	168
Naltrexone (extended-release, injectable, for example, Vivitrol^®)	5,594	3,586	137	922	187	504	94	164
Acamprosate (Campral^®)	3,880	2,375	156	611	192	332	75	139
Nicotine replacement	5,171	2,649	289	1,169	236	553	102	173
Non-nicotine smoking/tobacco cessation medications (for example, bupropion, varenicline)	4,238	2,573	154	721	190	388	77	135
Medications for psychiatric disorders	7,760	5,036	274	1,269	248	633	118	182
Methadone	1,582	1,396	63	37	21	30	17	18
Buprenorphine¹	6,497	4,281	217	998	221	491	116	173
Buprenorphine with naloxone (for example, Suboxone^®, Bunavail^®, Zubsolv^®, Cassipa^®)	6,183	4,096	183	953	204	471	108	168
Buprenorphine without naloxone	4,306	2,798	160	650	151	333	90	124
Buprenorphine sub-dermal implant (Probuphine^®)	538	315	11	105	9	67	6	25
Buprenorphine (extended-release, injectable, for example, Sublocade^®)	1,644	1,092	26	254	43	151	23	55
Medications for HIV treatment (for example, antiretroviral medications such as tenofovir, efavirenz, emtricitabine, atazanavir, and lamivudine)	1,301	480	114	375	76	147	35	74
Medications for hepatitis C (HCV) treatment (for example, sofosbuvir, ledipasvir, interferon, peginterferon, ribavirin)	1,416	621	89	371	67	155	38	75
Lofexidine	648	339	26	142	22	72	16	31
Clonidine	3,742	1,996	227	736	195	348	97	143
- - Quantity is zero.
Injectable naltrexone = extended-release injectable naltrexone.
¹ Buprenorphine total is not the sum of buprenorphine with and without naloxone and sub-dermal implant, because a facility can provide one or more forms of buprenorphine.
NOTES: Methadone is available only at OTP facilities that are certified by SAMHSA’s Center for Substance Abuse Treatment. Buprenorphine may be prescribed by medical practitioners who have received DATA 2000-specific training and received a waiver to prescribe the medication for treatment of opioid use disorder. Naltrexone may be prescribed by any medical practitioner with prescribing privileges. This report does not include clients who were prescribed buprenorphine through an independent DATA 2000-waivered medical practitioner or naltrexone through an independent practitioner not affiliated with a substance abuse treatment facility.
SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services (N-SSATS), 2019.

Table 4.9b. Services provided, by type of care: Column percent, 2019
Services	Total	Type of care
Services	Total	Outpatient only	Hospital inpatient only	Residential (non-hospital) only	Outpatient and hospital inpatient	Outpatient and residential (non-hospital)	Residential (non-hospital) and hospital inpatient	All three types of care
Assessment and pre-treatment services	99.0	99.6	99.4	95.8	100.0	99.2	98.5	100.0
Screening for substance abuse	96.8	98.1	94.2	90.4	98.1	96.4	94.7	100.0
Screening for mental disorders	77.4	78.8	80.3	66.3	92.7	79.4	87.0	90.8
Comprehensive substance abuse assessment or diagnosis	93.7	95.7	84.2	84.5	93.9	95.4	95.4	99.0
Comprehensive mental health assessment or diagnosis	56.2	57.4	69.7	41.6	82.8	58.9	74.0	83.2
Screening for tobacco use	72.5	71.9	89.7	68.5	88.1	75.2	82.4	85.7
Outreach to persons in community who may need treatment	64.4	66.3	47.7	54.2	65.5	72.0	61.1	71.4
Interim services for clients when immediate admission is not possible	48.0	51.5	22.3	31.9	41.4	57.5	34.4	56.1
Professional interventionist/educational consultant	18.2	18.4	12.9	16.3	16.5	19.5	29.0	28.1
Testing	90.9	88.1	98.4	98.0	99.6	98.7	99.2	100.0
Drug and alcohol oral fluid testing	25.9	27.3	12.6	23.6	15.3	24.0	24.4	19.9
Breathalyzer or other blood alcohol testing	64.1	57.3	80.3	80.2	92.3	83.4	83.2	92.9
Drug or alcohol urine screening	87.7	84.2	96.5	96.3	99.2	97.6	97.7	100.0
Testing for hepatitis B (HBV)	26.9	21.6	81.9	28.9	77.0	38.8	62.6	77.0
Testing for hepatitis C (HCV)	30.6	25.1	84.8	33.4	78.9	42.5	67.9	80.6
HIV testing	31.4	25.0	84.2	37.3	76.2	47.0	69.5	84.2
STD testing	25.6	19.7	82.3	29.5	76.6	38.7	67.9	78.6
TB screening	41.7	33.7	91.6	53.7	82.8	63.1	85.5	90.8
Testing for metabolic syndrome	8.1	7.0	32.3	4.9	37.9	9.0	19.1	24.0
Medical services	10.4	8.5	35.8	9.2	31.0	14.7	22.9	35.7
Hepatitis A (HAV) vaccination	9.6	8.0	28.7	8.7	28.7	13.3	22.1	32.1
Hepatitis B (HBV) vaccination	9.5	7.9	34.2	7.9	29.1	12.3	19.8	33.2
Transitional services	98.8	98.5	100.0	99.0	100.0	100.0	100.0	100.0
Discharge planning	95.4	94.2	100.0	98.0	100.0	98.9	99.2	99.5
Aftercare/continuing care	86.9	87.7	70.0	79.6	95.0	95.9	88.5	96.4
Naloxone and overdose education	50.2	47.2	59.0	55.3	62.1	58.1	78.6	74.0
Outcome follow-up after discharge	68.3	64.2	64.2	80.3	64.4	83.0	87.8	87.8
Recovery support services	88.2	84.5	92.9	97.9	95.0	99.2	100.0	98.5
Mentoring/peer support	61.3	54.8	50.3	81.9	56.7	84.3	71.8	82.1
Self-help groups	49.0	35.5	75.2	84.3	81.2	87.6	87.0	89.8
Assistance in locating housing for clients	61.2	55.0	52.9	80.2	55.6	83.8	79.4	82.1
Employment counseling or training for clients	43.0	39.1	11.3	58.5	19.9	62.8	42.7	55.6
Assistance with obtaining social services (for example, Medicaid, WIC, SSI, SSDI)	66.1	62.7	69.0	76.5	62.5	78.2	64.9	76.0
Recovery coach	22.6	21.4	12.3	25.0	16.9	33.4	30.5	31.6
Education and counseling services	99.5	99.6	96.5	98.9	100.0	99.8	100.0	100.0
HIV or AIDS education, counseling, or support	58.4	53.6	68.4	70.5	56.3	74.2	84.0	80.6
Hepatitis education, counseling, or support	52.8	47.5	68.7	65.3	53.6	68.9	86.3	81.1
Health education other than HIV/AIDS or hepatitis	56.8	50.8	73.2	70.5	67.8	76.1	85.5	83.2
Substance abuse education	97.0	96.7	93.2	97.6	95.8	99.2	100.0	99.5
Smoking/tobacco cessation counseling	57.3	53.6	80.3	62.2	83.5	67.2	77.9	82.7
Individual counseling	96.8	97.0	85.2	96.5	90.0	99.0	100.0	98.5
Group counseling	93.0	91.7	88.7	96.3	97.7	98.5	99.2	99.0
Family counseling	81.3	81.0	65.5	78.3	88.1	90.2	91.6	95.4
Marital/couples counseling	59.9	63.1	31.3	46.6	55.6	62.8	67.2	74.5
Vocational training or educational support	15.6	11.6	7.4	30.2	10.3	27.4	19.8	25.5
Ancillary services	96.3	95.8	95.2	97.5	98.1	99.0	99.2	99.5
Case management services	82.7	80.4	79.4	89.1	80.5	93.3	89.3	91.3
Social skills development	75.1	71.6	61.6	87.5	64.4	90.0	79.4	80.1
Child care for clients' children	5.9	4.7	.3	10.1	1.5	11.5	3.8	5.6
Domestic violence—family or partner violence services (physical, sexual, and emotional abuse)	38.3	38.8	22.9	35.6	34.1	42.8	45.8	44.9
Early intervention for HIV	23.0	19.7	28.4	31.0	24.5	33.9	41.2	41.3
Transportation assistance to treatment	46.2	39.4	42.9	64.7	54.8	70.3	67.2	75.0
Mental health services	69.6	69.7	72.9	61.6	90.8	75.9	85.5	87.2
Acupuncture	6.1	4.4	3.9	8.7	11.9	14.6	13.0	23.0
Residential beds for clients' children	2.5	- -	- -	11.7	- -	10.5	3.1	3.6
Other services	42.0	45.1	19.0	31.6	36.0	40.7	36.6	45.4
Treatment for gambling disorder	26.0	27.9	10.3	19.1	23.8	25.1	26.0	33.7
Treatment for Internet use disorder	15.1	16.8	2.6	10.1	11.9	13.2	13.0	15.3
Treatment for other addiction disorder (non- substance abuse)	34.6	37.6	13.9	25.0	29.5	31.6	28.2	35.7
Pharmacotherapies	65.3	62.0	99.7	64.1	100.0	76.0	96.2	97.4
Disulfiram (Antabuse^®)	23.3	20.6	45.2	21.6	64.8	30.2	45.8	60.2
Naltrexone (oral)	35.8	30.9	59.4	38.9	81.6	50.5	79.4	85.7
Naltrexone (extended-release, injectable, for example, Vivitrol^®)	35.0	30.9	44.2	37.2	71.6	50.9	71.8	83.7
Acamprosate (Campral^®)	24.3	20.5	50.3	24.7	73.6	33.5	57.3	70.9
Nicotine replacement	32.4	22.8	93.2	47.2	90.4	55.8	77.9	88.3
Non-nicotine smoking/tobacco cessation medications (for example, bupropion, varenicline)	26.6	22.2	49.7	29.1	72.8	39.2	58.8	68.9
Medications for psychiatric disorders	48.6	43.4	88.4	51.3	95.0	63.9	90.1	92.9
Methadone	9.9	12.0	20.3	1.5	8.0	3.0	13.0	9.2
Buprenorphine¹	40.7	36.9	70.0	40.3	84.7	49.5	88.5	88.3
Buprenorphine with naloxone (for example, Suboxone^®, Bunavail^®, Zubsolv^®, Cassipa^®)	38.7	35.3	59.0	38.5	78.2	47.5	82.4	85.7
Buprenorphine without naloxone	27.0	24.1	51.6	26.3	57.9	33.6	68.7	63.3
Buprenorphine sub-dermal implant (Probuphine^®)	3.4	2.7	3.5	4.2	3.4	6.8	4.6	12.8
Buprenorphine (extended-release, injectable, for example, Sublocade^®)	10.3	9.4	8.4	10.3	16.5	15.2	17.6	28.1
Medications for HIV treatment (for example, antiretroviral medications such as tenofovir, efavirenz, emtricitabine, atazanavir, and lamivudine)	8.2	4.1	36.8	15.1	29.1	14.8	26.7	37.8
Medications for hepatitis C (HCV) treatment (for example, sofosbuvir, ledipasvir, interferon, peginterferon, ribavirin)	8.9	5.4	28.7	15.0	25.7	15.6	29.0	38.3
Lofexidine	4.1	2.9	8.4	5.7	8.4	7.3	12.2	15.8
Clonidine	23.4	17.2	73.2	29.7	74.7	35.1	74.0	73.0
- - Quantity is zero.
Injectable naltrexone = extended-release injectable naltrexone.
¹ Buprenorphine total is not the sum of buprenorphine with and without naloxone and sub-dermal implant, because a facility can provide one or more forms of buprenorphine.
NOTES: Methadone is available only at OTP facilities that are certified by SAMHSA’s Center for Substance Abuse Treatment. Buprenorphine may be prescribed by medical practitioners who have received DATA 2000-specific training and received a waiver to prescribe the medication for treatment of opioid use disorder. Naltrexone may be prescribed by any medical practitioner with prescribing privileges. This report does not include clients who were prescribed buprenorphine through an independent DATA 2000-waivered medical practitioner or naltrexone through an independent practitioner not affiliated with a substance abuse treatment facility.
SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services (N-SSATS), 2019.

Table 4.10. Clinical/therapeutic approaches used frequently, by facility type: Number and column percent, 2019
Clinical/therapeutic approaches	Number of facilities				Column percent of facilities
Clinical/therapeutic approaches	Total	OTPs	Serving DUI and DWI¹	Non-OTP and non-DUI/DWI	Total	OTPs	Serving DUI and DWI¹	Non-OTP and non-DUI/DWI
Total	15,961	1,691	3,662	10,608	100.0	100.0	100.0	100.0
Substance abuse counseling	15,677	1,682	3,655	10,340	98.2	99.5	99.8	97.5
12-step facilitation	10,883	1,048	2,626	7,209	68.2	62.0	71.7	68.0
Brief intervention	13,087	1,373	3,164	8,550	82.0	81.2	86.4	80.6
Cognitive behavioral therapy	14,953	1,559	3,550	9,844	93.7	92.2	96.9	92.8
Dialectical behavior therapy	9,434	818	2,265	6,351	59.1	48.4	61.9	59.9
Contingency management/motivational incentives	8,809	1,050	2,016	5,743	55.2	62.1	55.1	54.1
Motivational interviewing	14,890	1,604	3,441	9,845	93.3	94.9	94.0	92.8
Trauma-related counseling	13,122	1,216	2,991	8,915	82.2	71.9	81.7	84.0
Anger management	12,922	1,219	3,105	8,598	81.0	72.1	84.8	81.1
Matrix model	7,141	697	1,987	4,457	44.7	41.2	54.3	42.0
Community reinforcement plus vouchers	1,743	180	462	1,101	10.9	10.6	12.6	10.4
Rational emotive behavioral therapy	6,885	657	1,915	4,313	43.1	38.9	52.3	40.7
Relapse prevention	15,332	1,651	3,581	10,100	96.1	97.6	97.8	95.2
Telemedicine/telehealth	4,386	349	1,010	3,027	27.5	20.6	27.6	28.5
Other treatment approaches	1,892	96	444	1,352	11.9	5.7	12.1	12.7
We do not use any of these clinical/therapeutic approaches	50	2	- -	48	0.3	0.1	- -	0.5
- - Quantity is zero.
DUI/DWI = driving under the influence/driving while intoxicated or impaired.
¹ Excludes OTP facilities.
SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services (N-SSATS), 2019.

Table 4.11a. Provision of MAT for opioid use disorder, by type of care: Number, 2019
Services	Total	Type of care
Services	Total	Outpatient only	Hospital inpatient only	Residential (non-hospital) only	Outpatient and hospital inpatient	Outpatient and residential (non-hospital)	Residential (non-hospital) and hospital inpatient	All three types of care
Total	15,961	11,596	310	2,476	261	991	131	196
Treats opioid use disorder	14,146	10,032	281	2,311	256	940	131	195
This facility uses methadone or buprenorphine, but it is not a federally certified opioid treatment program (OTP)	1,050	463	64	241	65	121	35	61
This facility treats opioid use disorder, but it does not use MAT, nor does it accept clients using MAT to treat opioid use disorder	1,374	835	24	361	8	131	8	7
This facility accepts clients using MAT, but the medications originate from or are prescribed by another entity	7,784	5,571	103	1,407	71	520	57	55
Prescribing entity in same network	1,960	1,274	37	415	27	159	30	18
Business, contractual, or formal referral relationship with prescribing entity	2,426	1,557	21	582	10	210	25	21
Clients obtain prescription from personal provider	5,996	4,396	74	1,018	56	376	42	34
Other	- -	- -	- -	- -	- -	- -	- -	- -
This facility administers naltrexone to treat opioid use disorder	5,493	3,461	161	901	217	484	101	168
This facility prescribes buprenorphine to treat opioid use disorder	5,286	3,513	156	755	195	403	102	162
This facility is a federally certified opioid treatment program (OTP)	1,691	1,453	66	55	28	39	24	26
Facility provides services to opioid use disorder clients only	1,251	1,224	4	14	- -	7	- -	2
- - Quantity is zero.
MAT = medication assisted treatment.
NOTES: Methadone is available only at OTP facilities that are certified by SAMHSA’s Center for Substance Abuse Treatment. Buprenorphine may be prescribed by medical practitioners who have received DATA 2000-specific training and received a waiver to prescribe the medication for treatment of opioid use disorder. Naltrexone may be prescribed by any medical practitioner with prescribing privileges. This report does not include clients who received or were prescribed buprenorphine through an independent DATA 2000-waivered medical practitioner or naltrexone through an independent practitioner not affiliated with a substance abuse treatment facility.
SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services (N-SSATS), 2019.

Table 4.11b. Provision of MAT for opioid use disorder, by type of care: Column percent, 2019
Services	Total	Type of care
Services	Total	Outpatient only	Hospital inpatient only	Residential (non-hospital) only	Outpatient and hospital inpatient	Outpatient and residential (non-hospital)	Residential (non-hospital) and hospital inpatient	All three types of care
Total	100.0	100.0	100.0	100.0	100.0	100.0	100.0	100.0
Treats opioid use disorder	88.6	86.5	90.6	93.3	98.1	94.9	100.0	99.5
This facility uses methadone or buprenorphine, but it is not a federally certified opioid treatment program (OTP)	6.6	4.0	20.6	9.7	24.9	12.2	26.7	31.1
This facility treats opioid use disorder, but it does not use MAT, nor does it accept clients using MAT to treat opioid use disorder	8.6	7.2	7.7	14.6	3.1	13.2	6.1	3.6
This facility accepts clients using MAT, but the medications originate from or are prescribed by another entity	48.8	48.0	33.2	56.8	27.2	52.5	43.5	28.1
Prescribing entity in same network	12.3	11.0	11.9	16.8	10.3	16.0	22.9	9.2
Business, contractual, or formal referral relationship with prescribing entity	15.2	13.4	6.8	23.5	3.8	21.2	19.1	10.7
Clients obtain prescription from personal provider	37.6	37.9	23.9	41.1	21.5	37.9	32.1	17.3
Other	- -	- -	- -	- -	- -	- -	- -	- -
This facility administers naltrexone to treat opioid use disorder	34.4	29.8	51.9	36.4	83.1	48.8	77.1	85.7
This facility prescribes buprenorphine to treat opioid use disorder	33.1	30.3	50.3	30.5	74.7	40.7	77.9	82.7
This facility is a federally certified opioid treatment program (OTP)	10.6	12.5	21.3	2.2	10.7	3.9	18.3	13.3
Facility provides services to opioid use disorder clients only	7.8	10.6	1.3	0.6	- -	0.7	- -	1.0
- - Quantity is zero.
MAT = medication assisted treatment.
NOTES: Methadone is available only at OTP facilities that are certified by SAMHSA’s Center for Substance Abuse Treatment. Buprenorphine may be prescribed by medical practitioners who have received DATA 2000-specific training and received a waiver to prescribe the medication for treatment of opioid use disorder. Naltrexone may be prescribed by any medical practitioner with prescribing privileges. This report does not include clients who received or were prescribed buprenorphine through an independent DATA 2000-waivered medical practitioner or naltrexone through an independent practitioner not affiliated with a substance abuse treatment facility.
SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services (N-SSATS), 2019.

Table 4.12. Approximate percentage of clients on MAT for opioid use disorder, by medication service: Number and row percent distribution: 2019
MAT service	Number of facilities					Row percent distribution of facilities
MAT service		Not offered¹	33% or less of clients	34% to 67% of clients	More than 67% of clients	Not offered¹	33% or less of clients	34% to 67% of clients	More than 67% of clients
Maintenance services with methadone or buprenorphine	7,493	2,462	1,632	862	2,537	32.9	21.8	11.5	33.9
Maintenance services with medically supervised withdrawal (or taper) after a period of stabilization	7,493	3,910	2,410	646	527	52.2	32.2	8.6	7.0
Detoxification from opioids of abuse with methadone or buprenorphine	7,493	5,150	1,154	548	641	68.7	15.4	7.3	8.6
Detoxification from opioids of abuse with lofexidine or clonidine	7,493	6,241	825	254	173	83.3	11.0	3.4	2.3
Relapse prevention with naltrexone	7,493	3,039	2,969	937	548	40.6	39.6	12.5	7.3
Other services	7,493	7,485	4	2	2	99.9	0.1	*	*
* Less than 0.05 percent.
MAT = medication assisted treatment.
¹ Facilities that did not provide a valid response are included in the category “not offered.”
NOTE: Percentages may not sum to 100 percent because of rounding.
SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services (N-SSATS), 2019.

Table 4.13. Treatment of alcohol use disorder, by facility operation: Number and column percent, 2019
Services	Facility operation
	Total	Number of facilities						Column percent of facilities
	Total	Private non-profit	Private for-profit	Local, county, or community govt.	State govt.	Federal govt.	Tribal govt.	Total	Private non-profit	Private for-profit	Local, county, or community govt.	State govt.	Federal govt.	Tribal govt.
Total	15,961	8,043	6,327	694	310	333	254	100.0
Treats alcohol use disorders	14,360	7,524	5,336	661	280	323	236	90.0	93.5	84.3	95.2	90.3	97.0	92.9
Treats alcohol use disorder without MAT	2,998	1,510	1,195	111	76	34	72	18.8	18.8	18.9	16.0	24.5	10.2	28.3
Treats clients with MAT with medications originating from another entity	7,731	4,234	2,800	381	112	70	134	48.4	52.6	44.3	54.9	36.1	21.0	52.8
Prescribing entity in same network	1,573	952	419	88	33	49	32	9.9	11.8	6.6	12.7	10.6	14.7	12.6
Business, contractual, or formal referral relationship with prescribing entity	2,063	1,160	699	119	35	20	30	12.9	14.4	11.0	17.1	11.3	6.0	11.8
Clients obtain prescription from personal provider	6,462	3,485	2,446	289	86	48	108	40.5	43.3	38.7	41.6	27.7	14.4	42.5
Other	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Administers/prescribes disulfiram, natrexone, or acamprosate	5,298	2,568	2,061	235	116	260	58	33.2	31.9	32.6	33.9	37.4	78.1	22.8
Treats alcohol use disorder clients only	155	66	62	7	3	10	7	1.0	0.8	1.0	1.0	1.0	3.0	2.8
- - Quantity is zero.
MAT = medication assisted treatment.
SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services (N-SSATS), 2019.

Table 4.14a. Provision of MAT for alcohol use disorder, by type of care: Number, 2019
Services	Total	Type of care
Services	Total	Outpatient only	Hospital inpatient only	Residential (non-hospital) only	Outpatient and hospital inpatient	Outpatient and residential (non-hospital)	Residential (non-hospital) and hospital inpatient	All three types of care
Total	15,961	11,596	310	2,476	261	991	131	196
Treats alcohol use disorders	14,360	10,122	291	2,401	259	965	127	195
Treats alcohol use disorder without MAT	2,998	2,129	61	538	38	192	22	18
Treats clients with MAT with medications originating from another entity	7,731	5,682	71	1,375	46	472	48	37
Prescribing entity in same network	1,573	1,022	17	355	16	125	25	13
Business, contractual, or formal referral relationship with prescribing entity	2,063	1,338	14	483	7	190	22	9
Clients obtain prescription from personal provider	6,462	4,869	55	1,076	39	359	37	27
Other	- -	- -	- -	- -	- -	- -	- -	- -
Administers/prescribes disulfiram, natrexone, or acamprosate	5,298	3,436	195	768	201	444	94	160
Treats alcohol use disorder clients only	155	113	6	21	4	7	1	3
- - Quantity is zero.
MAT = medication assisted treatment.
SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services (N-SSATS), 2019.

Table 4.14b. Provision of MAT for alcohol use disorder, by type of care: Column percent, 2019
Services	Total	Type of care
Services	Total	Outpatient only	Hospital inpatient only	Residential (non-hospital) only	Outpatient and hospital inpatient	Outpatient and residential (non-hospital)	Residential (non-hospital) and hospital inpatient	All three types of care
Treats alcohol use disorders	90.0	87.3	93.9	97.0	99.2	97.4	96.9	99.5
Treats alcohol use disorder without MAT	18.8	18.4	19.7	21.7	14.6	19.4	16.8	9.2
Treats clients with MAT with medications originating from another entity	48.4	49.0	22.9	55.5	17.6	47.6	36.6	18.9
Prescribing entity in same network	9.9	8.8	5.5	14.3	6.1	12.6	19.1	6.6
Business, contractual, or formal referral relationship with prescribing entity	12.9	11.5	4.5	19.5	2.7	19.2	16.8	4.6
Clients obtain prescription from personal provider	40.5	42.0	17.7	43.5	14.9	36.2	28.2	13.8
Other	- -	- -	- -	- -	- -	- -	- -	- -
Administers/prescribes disulfiram, natrexone, or acamprosate	33.2	29.6	62.9	31.0	77.0	44.8	71.8	81.6
Treats alcohol use disorder clients only	1.0	1.0	1.9	0.8	1.5	0.7	0.8	1.5
- - Quantity is zero.
MAT = medication assisted treatment.
SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services (N-SSATS), 2019.

Table 4.15a. Facilities offering special programs or groups for specific client types, by facility operation: Number, 2019
Facility operation			Client type
Facility operation	Total¹	Any program or group	Adolescents	Young adults	Adult women	Pregnant or post-partum women	Adult men	Seniors or older adults	LGBT	Veterans	Active duty military	Members of military families	Criminal justice clients	Clients with co-occurring mental and substance use disorders	Clients with co-occurring pain and substance use	Clients with HIV or AIDS	Clients who have experienced sexual abuse	Clients who have experienced intimate partner or domestic violence	Clients who have experienced trauma	DUI/DWI clients	Other	No specifically tailored program or group offered²
Total	15,961	13,004	3,814	4,929	7,835	3,875	7,504	3,701	3,600	3,459	1,995	2,285	5,748	8,384	2,990	3,181	4,509	4,491	6,812	3,826	757	2,957
Facility operation
Private non-profit	8,043	6,710	2,151	2,344	3,860	1,847	3,634	1,605	1,645	1,412	685	886	3,093	4,390	1,261	1,596	2,142	2,109	3,535	1,696	315	1,333
Private for-profit	6,327	5,009	1,247	2,222	3,250	1,695	3,237	1,840	1,719	1,641	1,137	1,262	2,137	3,176	1,502	1,366	2,007	2,022	2,607	1,853	345	1,318
Local, county, or community govt.	694	556	223	146	342	160	299	81	79	71	28	41	272	359	59	68	125	118	273	149	23	138
State government	310	239	71	87	146	77	125	52	49	50	17	19	97	171	43	63	74	81	122	47	22	71
Federal govt.	333	299	9	38	114	32	92	53	50	228	96	39	62	178	85	40	81	67	162	27	5	34
Dept. of Veterans Affairs	222	211	- -	18	81	21	63	43	39	206	37	20	52	136	68	33	64	50	134	12	4	11
Dept. of Defense	69	62	- -	10	21	4	17	3	5	18	58	17	3	23	13	3	10	10	18	10	- -	7
Indian Health Service	31	23	9	8	9	5	10	6	5	4	1	2	6	16	3	3	6	6	9	5	1	8
Other	11	3	- -	2	3	2	2	1	1	- -	- -	- -	1	3	1	1	1	1	1	- -	- -	8
Tribal government	254	191	113	92	123	64	117	70	58	57	32	38	87	110	40	48	80	94	113	54	47	63
- - Quantity is zero.
DUI/DWI = driving under the influence/driving while intoxicated or impaired; LGBT = lesbian, gay, bisexual, or transgender.
¹ Number of facilities sums to more than the total column, because a facility could offer special programs or groups for more than one client type.
² Facilities that did not indicate they provided any of the listed programs or groups, or a program or group tailored specifically for other types of clients, are assigned to “no program or group offered.”
SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services (N-SSATS), 2019.

Table 4.15b. Facilities offering special programs or groups for specific client types, by facility operation: Row percent, 2019
Facility operation			Client type
Facility operation	Total¹	Any program or group	Adolescents	Young adults	Adult women	Pregnant or post-partum women	Adult men	Seniors or older adults	LGBT	Veterans	Active duty military	Members of military families	Criminal justice clients	Clients with co-occurring mental and substance use disorders	Clients with co-occurring pain and substance use	Clients with HIV or AIDS	Clients who have experienced sexual abuse	Clients who have experienced intimate partner or domestic violence	Clients who have experienced trauma	DUI/DWI clients	Other	No specifically tailored program or group offered²
Total	15,961	81.5	23.9	30.9	49.1	24.3	47.0	23.2	22.6	21.7	12.5	14.3	36.0	52.5	18.7	19.9	28.3	28.1	42.7	24.0	4.7	18.5
Facility operation
Private non-profit	8,043	83.4	26.7	29.1	48.0	23.0	45.2	20.0	20.5	17.6	8.5	11.0	38.5	54.6	15.7	19.8	26.6	26.2	44.0	21.1	3.9	16.6
Private for-profit	6,327	79.2	19.7	35.1	51.4	26.8	51.2	29.1	27.2	25.9	18.0	19.9	33.8	50.2	23.7	21.6	31.7	32.0	41.2	29.3	5.5	20.8
Local, county, or community govt.	694	80.1	32.1	21.0	49.3	23.1	43.1	11.7	11.4	10.2	4.0	5.9	39.2	51.7	8.5	9.8	18.0	17.0	39.3	21.5	3.3	19.9
State government	310	77.1	22.9	28.1	47.1	24.8	40.3	16.8	15.8	16.1	5.5	6.1	31.3	55.2	13.9	20.3	23.9	26.1	39.4	15.2	7.1	22.9
Federal government	333	89.8	2.7	11.4	34.2	9.6	27.6	15.9	15.0	68.5	28.8	11.7	18.6	53.5	25.5	12.0	24.3	20.1	48.6	8.1	1.5	10.2
Dept. of Veterans Affairs	222	95.0	- -	8.1	36.5	9.5	28.4	19.4	17.6	92.8	16.7	9.0	23.4	61.3	30.6	14.9	28.8	22.5	60.4	5.4	1.8	5.0
Dept. of Defense	69	89.9	- -	14.5	30.4	5.8	24.6	4.3	7.2	26.1	84.1	24.6	4.3	33.3	18.8	4.3	14.5	14.5	26.1	14.5	- -	10.1
Indian Health Service	31	74.2	29.0	25.8	29.0	16.1	32.3	19.4	16.1	12.9	3.2	6.5	19.4	51.6	9.7	9.7	19.4	19.4	29.0	16.1	3.2	25.8
Other	11	27.3	- -	18.2	27.3	18.2	18.2	9.1	9.1	- -	- -	- -	9.1	27.3	9.1	9.1	9.1	9.1	9.1	- -	- -	72.7
Tribal government	254	75.2	44.5	36.2	48.4	25.2	46.1	27.6	22.8	22.4	12.6	15.0	34.3	43.3	15.7	18.9	31.5	37.0	44.5	21.3	18.5	24.8
- - Quantity is zero.
DUI/DWI = driving under the influence/driving while intoxicated or impaired; LGBT = lesbian, gay, bisexual, or transgender.
¹ Percentages sum to more than 100 percent, because a facility could offer special programs or groups for more than one client type.
² Facilities that did not indicate they provided any of the listed programs or groups, or a program or group tailored specifically for other types of clients, are assigned to “no program or group offered.”
SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services (N-SSATS), 2019.

Table 4.16a. Facilities offering substance use treatment services in sign language for the deaf and hard-of-hearing and in languages other than English, by facility operation: Number, 2019
Facility operation	Total	Sign language	Any language other than English	Language services provided by			Languages provided by staff counselor¹
Facility operation	Total	Sign language	Any language other than English	Staff counselor only	On-call interpreter only²	Both staff counselor and on-call interpreter	Spanish	American Indian/Alaska Native language	Other
Total	15,961	5,580	8,410	1,969	4,329	2,112	3,826	91	832
Facility operation
Private non-profit	8,043	3,629	4,955	932	2,825	1,198	2,030	30	370
Private for-profit	6,327	1,161	2,456	919	886	651	1,466	24	405
Local, county, or community govt.	694	471	566	55	322	189	232	- -	43
State government	310	174	218	29	153	36	61	- -	12
Federal government	333	96	132	6	100	26	28	4	2
Dept. of Veterans Affairs	222	70	94	4	73	17	21	- -	1
Dept. of Defense	69	17	20	1	16	3	4	- -	- -
Indian Health Service	31	6	12	1	7	4	1	4	1
Other	11	3	6	- -	4	2	2	- -	- -
Tribal government	254	49	83	28	43	12	9	33	- -
Facility type
OTPs	1,691	545	1,060	345	356	359	682	2	165
DUI/DWI clients³	3,662	1,139	1,965	605	872	488	1,019	28	226
Non-OTP and non-DUI/DWI	10,608	3,896	5,385	1,019	3,101	1,265	2,125	61	441
- - Quantity is zero.
DUI/DWI = driving under the influence/driving while intoxicated or impaired.
¹ Number of facilities based on facilities where language services are provided by staff counselors only and by both staff counselors and on-call interpreters.
² Facilities that offered substance use treatment services in any language other than English but which did not have a valid response to language provider were classified as providing services by an on-call interpreter only.
³ Excludes OTP facilities.
SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services (N-SSATS), 2019.

Table 4.16b. Facilities offering substance use treatment services in sign language for the deaf and hard-of-hearing and in languages other than English, by facility operation: Row percent distribution, 2019
Facility operation	Number of facilities	Sign language	Any language other than English	Language services provided by				Languages provided by staff counselor¹
Facility operation	Number of facilities	Sign language	Any language other than English	Total	Staff counselor only	On-call interpreter only²	Both staff counselor and on-call interpreter	Spanish	American Indian/Alaska Native language	Other
Total	15,961	35.0	52.7	100.0	23.4	51.5	25.1	93.8	2.2	20.4
Facility operation
Private non-profit	8,043	45.1	61.6	100.0	18.8	57.0	24.2	95.3	1.4	17.4
Private for-profit	6,327	18.3	38.8	100.0	37.4	36.1	26.5	93.4	1.5	25.8
Local, county, or community govt.	694	67.9	81.6	100.0	9.7	56.9	33.4	95.1	- -	17.6
State government	310	56.1	70.3	100.0	13.3	70.2	16.5	93.8	- -	18.5
Federal government	333	28.8	39.6	100.0	4.5	75.8	19.7	87.5	12.5	6.3
Dept. of Veterans Affairs	222	31.5	42.3	100.0	4.3	77.7	18.1	100.0	- -	4.8
Dept. of Defense	69	24.6	29.0	100.0	5.0	80.0	15.0	100.0	- -	- -
Indian Health Service	31	19.4	38.7	100.0	8.3	58.3	33.3	20.0	80.0	20.0
Other	11	27.3	54.5	100.0	- -	66.7	33.3	100.0	- -	- -
Tribal government	254	19.3	32.7	100.0	33.7	51.8	14.5	22.5	82.5	- -
Facility type
OTPs	1,691	32.2	62.7	100.0	32.5	33.6	33.9	96.9	0.3	23.4
DUI/DWI clients³	3,662	31.1	53.7	100.0	30.8	44.4	24.8	93.2	2.6	20.7
Non-OTP and non-DUI/DWI	10,608	36.7	50.8	100.0	18.9	57.6	23.5	93.0	2.7	19.3
- - Quantity is zero.
DUI/DWI = driving under the influence/driving while intoxicated or impaired.
¹ Percentage of facilities based on facilities where language services are provided by staff counselors only and by both staff counselors and on-call interpreters.
² Facilities that offered substance use treatment services in any language other than English but which did not have a valid response to language provider were classified as providing services by an on-call interpreter only.
³ Excludes OTP facilities.
SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services (N-SSATS), 2019.

Table 4.17. Facilities detoxifying clients, by substance and facility operation: Number and row percent, 2019
Facility operation	Number of facilities¹								Row percent of facilities¹
	Total²	Detoxification from						Routine use of medica-tions during detox	Detoxification from						Routine use of medica- tions during detox
	Total²	Opioids	Alcohol	Benzo-diaze-pines	Cocaine	Meth-amphet-amines	Other sub-stances	Routine use of medica-tions during detox	Opioids	Alcohol	Benzo-diaze-pines	Cocaine	Meth-amphet-amines	Other sub-stances	Routine use of medica- tions during detox
Total	3,508	3,342	2,488	2,320	2,093	2,110	476	3,154	95.3	70.9	66.1	59.7	60.1	13.6	89.9
Facility operation
Private non-profit	1,334	1,253	968	856	770	782	169	1,103	93.9	72.6	64.2	57.7	58.6	12.7	82.7
Private for-profit	1,869	1,814	1,266	1,243	1,162	1,156	290	1,772	97.1	67.7	66.5	62.2	61.9	15.5	94.8
Local, county, or community govt.	97	90	85	72	55	54	7	85	92.8	87.6	74.2	56.7	55.7	7.2	87.6
State government	58	53	44	41	30	37	5	54	91.4	75.9	70.7	51.7	63.8	8.6	93.1
Federal government	136	119	117	102	71	75	4	128	87.5	86.0	75.0	52.2	55.1	2.9	94.1
Dept. of Veterans Affairs	126	112	111	100	67	70	4	120	88.9	88.1	79.4	53.2	55.6	3.2	95.2
Dept. of Defense	5	3	3	1	1	1	- -	5	60.0	60.0	20.0	20.0	20.0	- -	100.0
Indian Health Service	3	2	2	- -	1	2	- -	2	66.7	66.7	- -	33.3	66.7	- -	66.7
Other	2	2	1	1	2	2	- -	1	100.0	50.0	50.0	100.0	100.0	- -	50.0
Tribal government	14	13	8	6	5	6	1	12	92.9	57.1	42.9	35.7	42.9	7.1	85.7
- - Quantity is zero.
¹ Number of facilities sums to more than the total column, and percentages sum to more than 100 percent, because a facility could provide detoxification for more than one substance.
² Of 15,961 facilities, 3,508 facilities (22 percent) offered detoxification services.
SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services (N-SSATS), 2019.

Table 4.18. Facilities with client outreach, by facility operation: Number and percent, 2019
Facility operation	Total number of facilities	Outreach to persons who may need treatment
Facility operation	Total number of facilities	Number of facilities	Percent of all facilities
Total	15,961	10,282	64.4
Facility operation
Private non-profit	8,043	5,391	67.0
Private for-profit	6,327	3,760	59.4
Local, county, or community government	694	515	74.2
State government	310	189	61.0
Federal government	333	213	64.0
Dept. of Veterans Affairs	222	151	68.0
Dept. of Defense	69	32	46.4
Indian Health Service	31	25	80.6
Other	11	5	45.5
Tribal government	254	214	84.3
SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services (N-SSATS), 2019.

Table 4.19a. Facility licensing, certification, or accreditation, by facility operation: Number, 2019
Facility operation	Total¹	Any listed agency/ organization	Licensing, certification, or accreditation organization
Facility operation	Total¹	Any listed agency/ organization	State substance abuse agency	State mental health department	State department of health	Hospital licensing authority	Joint Commission	CARF	NCQA	COA	HFAP	Other national organization or federal/state/ local agency
Total	15,961	15,035	12,461	6,338	7,521	825	3,643	4,705	364	701	162	680
Facility operation
Private non-profit	8,043	7,746	6,628	3,665	3,843	465	1,569	2,626	221	485	87	275
Private for-profit	6,327	5,814	4,835	2,106	3,109	217	1,606	1,635	111	188	49	293
Local, county, or community govt.	694	671	602	358	318	39	81	145	7	12	6	21
State government	310	297	241	148	154	29	88	129	8	2	11	12
Federal government	333	316	34	10	20	65	274	129	12	9	7	22
Dept. of Veterans Affairs	222	219	13	6	7	48	215	118	11	9	5	10
Dept. of Defense	69	63	5	- -	2	13	50	8	- -	- -	1	7
Indian Health Service	31	27	12	4	9	4	7	3	1	- -	1	5
Other	11	7	4	- -	2	- -	2	- -	- -	- -	- -	- -
Tribal government	254	191	121	51	77	10	25	41	5	5	2	57
Facility type
OTPs	1,691	1,688	1,508	531	1,057	118	484	1,135	50	90	16	190
DUI/DWI clients²	3,662	3,550	3,251	1,688	1,631	87	392	791	65	119	43	119
Non-OTP and non-DUI/DWI	10,608	9,797	7,702	4,119	4,833	620	2,767	2,779	249	492	103	371
- - Quantity is zero.
CARF = Commission on Accreditation of Rehabilitation Facilities; COA = Council on Accreditation; DUI/DWI = driving under the influence/driving while intoxicated or impaired; HFAP = Healthcare Facilities Accreditation Program; NCQA = National Committee for Quality Assurance.
¹ Number of facilities sums to more than the total column, because a facility could report more than one licensing, certification, or accreditation organization.
² Excludes OTP facilities.
SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services (N-SSATS), 2019.

Table 4.19b. Facility licensing, certification, or accreditation, by facility operation: Row percent, 2019
Facility operation	Number of facilities¹	Any listed agency/ organization	Licensing, certification, or accreditation organization
Facility operation	Number of facilities¹	Any listed agency/ organization	State substance abuse agency	State mental health department	State department of health	Hospital licensing authority	Joint Commission	CARF	NCQA	COA	HFAP	Other national organization or federal/state/ local agency
Total	15,961	94.2	78.1	39.7	47.1	5.2	22.8	29.5	2.3	4.4	1.0	4.3
Facility operation
Private non-profit	8,043	96.3	82.4	45.6	47.8	5.8	19.5	32.6	2.7	6.0	1.1	3.4
Private for-profit	6,327	91.9	76.4	33.3	49.1	3.4	25.4	25.8	1.8	3.0	0.8	4.6
Local, county, or community govt.	694	96.7	86.7	51.6	45.8	5.6	11.7	20.9	1.0	1.7	0.9